Self-Limited Epilepsy with Autonomic Seizures

Complex MONDO:0020307 Pathograph 7 Show in embeddings browser Epilepsy Neurological Disease

Self-limited epilepsy with autonomic seizures, long known as Panayiotopoulos syndrome, is a childhood focal epilepsy whose seizures are made almost entirely of autonomic symptoms. The child typically retains awareness at onset while going pale and vomiting repeatedly, and the episode commonly runs past thirty minutes, which makes autonomic status epilepticus the rule rather than a complication. Two thirds of seizures happen in sleep. The EEG shows shifting multifocal spikes, classically occipital in the youngest children but migrating with age. Seizures are usually few, remission within a few years is the norm, and the adult epilepsy risk is not raised above the population. The clinical problem is not the epilepsy but the mimicry: prolonged vomiting with altered responsiveness in a young child is routinely mistaken for encephalitis, gastroenteritis, migraine, or syncope.

Ask OpenScientist

Ask a research question about Self-Limited Epilepsy with Autonomic Seizures. OpenScientist will conduct autonomous deep research using the Disorder Mechanisms Knowledge Base and PubMed literature (typically 10-30 minutes).

Submitting...

Do not include personal health information in your question. Questions and results are cached in your browser's local storage.

1
Mappings
6
Pathophys.
10
Phenotypes
4
Gaps
7
Pathograph
3
Medical Actions
4
Differentials
2
References
1
Deep Research
🔗

Mappings

MONDO
MONDO:0020307 self-limited epilepsy with autonomic seizures
skos:exactMatch MONDO
MONDO:0020307 is the self-limited epilepsy with autonomic seizures concept, the ILAE 2022 name for what was previously called Panayiotopoulos syndrome.
?

Discussions and Knowledge Gaps

4
The published account holds that ictal discharges in this syndrome produce emesis and autonomic disturbance irrespective of where they begin. What circuit property of the young brain makes autonomic networks recruitable from anywhere, and why does that property disappear with age?
KNOWLEDGE GAP OPEN seleas_why_autonomic_and_location_independent
Attached to
pathophysiology#Age-Specific Vulnerability of Central Autonomic Networks pathophysiology#Multifocal Cortical Epileptogenicity with Age-Shifting Foci
This is the central unexplained fact of the syndrome, and it is unusual enough to be worth stating plainly. In almost every other focal epilepsy, semiology localizes: an auditory aura implies auditory cortex, an epigastric rising sensation implies mesial temporal onset. Here the relationship is broken in both directions. The EEG foci are multifocal and migrate through occipital, frontopolar, and centro-parieto-temporal locations across childhood, yet the seizures remain stereotypically emetic throughout. The published resolution is to place the specificity not in the cortical generator but in the target: children's central autonomic networks are held to be particularly vulnerable to recruitment, so wherever the discharge starts, the autonomic system is what expresses it. If that is right it is a genuinely different architecture from the usual localizationist picture, and it should be testable. Two things make it more than a restatement of the observation. First, the same seizure sequence does not occur in adults, so whatever the property is, it is developmental and it closes. Second, the syndrome remits on roughly the same timescale over which the property is said to disappear, which raises the possibility that the maturation of autonomic network resilience is not merely permissive but is the thing that ends the epilepsy. No cellular or circuit-level account of the susceptibility exists in the cited literature.
Proposed experiments
Test whether seizure semiology varies with EEG onset location
exp_seleas_onset_zone_versus_semiology
Within a cohort of children with this syndrome, relate ictal onset location on video-EEG to the autonomic semiology of the corresponding seizure, testing directly whether emetic manifestations are independent of onset zone as the location-independence claim requires.
Decision criterion
Equivalent emetic semiology across different onset zones would confirm location independence and support placing the specificity in the autonomic target; systematic variation with onset location would mean the syndrome is localizationist after all and the current account needs revision.
Developmental time-course of central autonomic network recruitability
exp_autonomic_network_maturation_timecourse
Characterize the maturation of central autonomic network connectivity across the relevant age range in typically developing children and in affected children, and test whether the timing of remission tracks a measurable change in that network rather than a change in cortical excitability.
Decision criterion
Remission coinciding with autonomic-network maturation rather than with loss of cortical spikes would establish the autonomic target as the rate-limiting element and would reframe the syndrome as a disorder of autonomic recruitability rather than of cortical excitability.
Show evidence (3 references)
PMID:16950946 SUPPORT Other
"Ictal epileptic discharges in Panayiotopoulos syndrome, irrespective of their location at onset, activate autonomic disturbances and emesis, to which children are particularly vulnerable."
The location-independence claim that this gap is about, stated explicitly in the authoritative clinical review.
PMID:16950946 SUPPORT Human Clinical
"The symptoms/sequence of autonomic seizures and autonomic status epilepticus in Panayiotopoulos syndrome are specific to childhood, and they do not occur in adults."
Establishes that the susceptibility is developmental and closes with age, which is the second half of the puzzle.
PMID:37660659 SUPPORT Other
"The interictal EEG characteristics of SeLEAS are multifocal EEG foci with age-dependent predominant locations; occipital (O) at 2-5 years old, and occipital and frontopolar (synchronous and independent O and Fp spikes) at 4-7 years old and centro-parieto-temporal (CPT) at 6-10 years old."
Documents that the cortical generator moves while the semiology does not, which is what makes the location-independence claim necessary in the first place.
Is this syndrome electrographically defined by occipital spikes or by multifocal spikes, and is the evidence base strong enough to support any EEG criterion being definitional?
CONTROVERSY UNDER DISCUSSION seleas_occipital_versus_multifocal_definition
Attached to
pathophysiology#Multifocal Cortical Epileptogenicity with Age-Shifting Foci
The syndrome's naming history is a record of this argument. It was once called early-onset benign childhood occipital epilepsy, a name asserting that the occipital lobe was where the disease lived. The ILAE 2022 reclassification abandoned that and named the syndrome for its autonomic semiology instead, and the current definition characterizes the EEG as multifocal. Both descriptions are partly right, which is the problem: the foci genuinely are occipital-predominant in the youngest children, and genuinely are multifocal and migrating across the whole age range, so a cross-sectional study will report whichever depending on the ages it sampled. A 2023 reappraisal of the EEG literature found that although enough cases have been studied, almost none of the studies analysed cross-sectional and longitudinal change systematically, and proposed an explicitly age-stratified EEG definition on that limited basis. The stake is practical: if occipital predominance is expected only at 2 to 5 years, then applying it as a diagnostic criterion in a 9-year-old will produce false negatives, and conversely a multifocal criterion may be too loose to exclude other childhood epilepsies.
Proposed experiments
Longitudinal EEG cohort with serial recordings through remission
exp_seleas_longitudinal_eeg_cohort
A prospective cohort with serial EEG from diagnosis through remission, analysed longitudinally rather than cross-sectionally, to establish whether the proposed age-stratified focus distribution is reproducible within individual children.
Decision criterion
Reproducible within-child migration through the proposed sequence would justify an age-stratified EEG criterion; heterogeneous trajectories would mean no single EEG criterion should be definitional.
Discriminative performance of candidate EEG criteria
exp_seleas_eeg_criterion_discrimination
Test occipital-predominant versus multifocal EEG criteria for sensitivity and specificity against other childhood focal epilepsies, stratified by age at recording.
Decision criterion
A criterion achieving useful specificity against the sibling centrotemporal syndrome and other childhood epilepsies could be adopted as definitional; poor discrimination would confirm that the syndrome should remain semiologically rather than electrographically defined.
Show evidence (3 references)
PMID:37660659 SUPPORT Other
"Although previous studies investigated the details of interictal EEG characteristics in a sufficient number of SeLEAS cases, there were few systematically analyzing cross sectional and longitudinal EEG changes except one study."
States the evidential weakness underlying any EEG criterion for this syndrome, which is the core of the controversy.
PMID:37660659 SUPPORT Other
"Despite these limited evidence, I propose the following practical and useful EEG definition."
The author explicitly acknowledges proposing a definition on limited evidence, which is why this is recorded as an open controversy rather than as settled criteria.
PMID:35503717 SUPPORT Other
"Based on the 2017 Classification of Seizures and Epilepsies, some syndrome names have been updated using terms directly describing the seizure semiology."
Documents the ILAE's shift to semiology-based naming, which is what moved this syndrome away from its occipital label.
Is cognition genuinely normal in this syndrome, as the syndrome definition asserts, or is there a mild diffuse comorbidity that group-level normality conceals?
CONTROVERSY OPEN seleas_cognitive_comorbidity_contested
Attached to
pathophysiology#Multifocal Cortical Epileptogenicity with Age-Shifting Foci pathophysiology#Age-Dependent Remission
Stated as a contradiction this looks unresolvable, but the two principal studies actually agree on the data and differ on what to call it, which is a more tractable disagreement. A consecutive series of 93 patients found IQ and Wechsler subtests within normal limits, while also finding statistically significant differences against controls on arithmetic, comprehension, and picture arrangement. A smaller retrospective series of 18 found mean full-scale IQ of 93.5, explicitly within the normal range yet significantly below the normative mean, with reaction times, visual attention, visual-motor integration, and verbal memory all significantly lower, an average lag of 8 months in arithmetic speed and 11 months in reading speed, and elevated internalizing behavioural problems. Both studies therefore report normal-range performance alongside reproducible sub-normative differences. The larger study reads that as normality with minor variation; the smaller reads the same shape as diffuse cognitive dysfunction and comorbidity. Three things make this worth resolving rather than splitting the difference. First, the syndrome definition asserts normal development, and a definitional claim that the data only support at group level will systematically miss the affected minority; more than half of the children in the smaller series had mild-to-severe academic underachievement, which a normal mean IQ conceals entirely. Second, the deficits reported are exactly the domains that an interictal multifocal spike burden would be expected to touch, so the question connects to the pathograph rather than being purely clinical. Third, the smaller series is 18 children assessed at a mean age of 4 years 7 months, near the peak of the electrographic abnormality, whereas the syndrome's premise is that everything resolves by adolescence, so the two studies may be sampling different points on a trajectory rather than disagreeing about a fixed state. Neither followed cognition longitudinally through remission, which is the study that would settle it.
Proposed experiments
Longitudinal neuropsychology from diagnosis through remission
exp_seleas_longitudinal_cognition_through_remission
Serial neuropsychological and academic assessment of the same children from diagnosis through EEG normalization and seizure remission, with matched controls, testing whether the sub-normative differences track the spike burden and resolve with it or persist after remission.
Decision criterion
Deficits that resolve as the foci disappear would support a transient comorbidity of the active phase and vindicate the self-limited framing; deficits persisting beyond remission would mean the syndrome leaves a cognitive trace and the definition's claim of normal development needs qualifying.
Interictal spike burden against domain-specific performance
exp_seleas_spike_burden_versus_cognition
Relate quantified interictal spike burden and focus location on extended EEG to performance in the specific domains reported as affected, namely visual attention, visual-motor integration, verbal memory, and arithmetic and reading speed.
Decision criterion
A dose relationship between spike burden and domain performance would make the comorbidity mechanistically attributable to the epilepsy rather than incidental, and would identify the children worth monitoring.
Show evidence (4 references)
PMID:20528983 SUPPORT Human Clinical
"On neuropsychological testing, IQ and subtests of Wechsler Intelligence Scale for Children-Revised (WISC-R) were within normal limits, although some minor statistically significant differences were found in arithmetic, comprehension, and picture arrangement in comparison with controls."
The larger series, and the normality side of the disagreement. Note it contains both halves: normal limits overall, yet reproducible differences against controls in specific domains.
PMID:32608507 SUPPORT Human Clinical
"Mean full-scale IQ (93.5; range 76-123; p=0.04) and performance IQ (93.2; range 76-126; p=0.04) were within the normal range, although significantly lower compared to the normative mean."
The comorbidity side, and the sentence that shows the disagreement is interpretive rather than empirical: the same pattern of normal-range but sub-normative performance is reported, and read differently.
PMID:32608507 SUPPORT Human Clinical
"On average, patients with Panayiotopoulos syndrome were 8 months behind in arithmetic speed and 11 months behind in reading speed for the number of months in school."
The concrete academic consequence, which is what makes the distinction matter beyond psychometrics. A group mean IQ in the normal range does not tell a family whether their child is losing school months.
+ 1 more reference
The syndrome is named self-limited and described as remarkably benign, yet it can evolve into encephalopathy with status epilepticus in sleep and measurable cognitive decline, and rare cardiorespiratory arrest is acknowledged. Does the benign label adequately convey the residual risk?
CONTROVERSY OPEN seleas_is_self_limited_label_safe
Attached to
pathophysiology#Age-Dependent Remission pathophysiology#Autonomic Status Epilepticus
The benign framing is well earned for the typical patient: seizures are few, prolonged episodes leave no deficit, and adult epilepsy risk returns to baseline. That framing also does real clinical work, since it is what justifies not treating and what breaks the misdiagnosis cycle. But two things sit uneasily with it. First, an atypical evolution exists in which occipital foci progress to synchronous frontopolar and occipital spikes and then to continuous spike-wave in sleep, with neuropsychological ability including IQ deteriorating during that period. In the reported cases the children ultimately recovered and came off medication, so even the atypical course was ultimately self-limited, but the cognitive decline was real while it lasted. Second, the same review that calls the syndrome remarkably benign also notes that autonomic seizures are potentially life-threatening in the rare context of cardiorespiratory arrest and states that this needs further study. The tension is not that the label is wrong but that it is a statement about the central tendency being applied to an individual patient, and the features that would identify the minority at risk, the reported candidate being the frontopolar-occipital focus combination, are not validated as predictors. The curation question is whether this entry should model the atypical evolution as a distinct trajectory rather than as an exception to a benign course.
Proposed experiments
Prospective identification of predictors of atypical evolution
exp_seleas_predictors_of_atypical_evolution
A prospective cohort with serial EEG and neuropsychological assessment, testing whether the frontopolar-occipital focus combination, seizure burden, or age at onset predicts progression to continuous spike-wave in sleep and cognitive decline.
Decision criterion
A validated predictor would justify stratified surveillance and would support modelling the atypical evolution as a separate trajectory; absence of any predictor would support retaining the benign framing with routine monitoring for all.
Quantification of cardiorespiratory risk during autonomic seizures
exp_seleas_cardiorespiratory_risk_quantification
Systematic cardiorespiratory monitoring during autonomic seizures and autonomic status epilepticus in this syndrome, to establish whether the acknowledged rare risk of cardiorespiratory arrest is quantifiable and whether any seizure feature precedes it.
Decision criterion
A measurable and predictable risk would change management advice for prolonged episodes; confirmation that events are vanishingly rare and unpredictable would support the current conservative approach.
Show evidence (4 references)
PMID:32020894 SUPPORT Human Clinical
"Neuropsychological ability, including IQ, deteriorated during the CSWS period in both patients."
Documents measurable cognitive decline during the atypical evolution, which is the observation that sits most awkwardly with an unqualified benign label.
PMID:32020894 SUPPORT Human Clinical
"PS can progress to ESES if the clinical course exhibits atypical evolution. The initial autonomic symptom of the seizures and interictal Fp-O EEG foci should be carefully monitored in patients with CSWS or ESES."
States both the atypical evolution and the candidate warning feature, the frontopolar-occipital focus combination, that a stratified approach would need to validate.
PMID:32020894 SUPPORT Human Clinical
"However, the seizures and EEG findings gradually resolved, and AEDs were successfully terminated in both patients."
The counterweight: even the atypical course ultimately remitted, which is why this is recorded as a live tension rather than as a refutation of the self-limited label. PARTIAL because two cases cannot establish the general outcome of atypical evolution.
+ 1 more reference
⚙

Pathophysiology

6
Maturational Seizure Susceptibility of the Developing Brain
The proposed substrate is not a lesion but a developmental window. The leading account treats this syndrome and self-limited epilepsy with centrotemporal spikes as the early-onset and late-onset phenotypes of one maturation-related childhood seizure-susceptibility state, which is why both remit and why neither leaves a deficit. Nothing structural is demonstrable, and the syndrome's boundaries are set by age rather than by anatomy.
Downstream
Multifocal Cortical Epileptogenicity with Age-Shifting Foci
Age-Specific Vulnerability of Central Autonomic Networks
Show evidence (1 reference)
PMID:16950946 SUPPORT Other
"Panayiotopoulos syndrome is probably the early-onset and Rolandic epilepsy the late-onset phenotype of a maturation-related benign childhood seizure-susceptibility syndrome."
States the maturational-susceptibility account and its relationship to the centrotemporal-spike syndrome, which is exactly what this node asserts. Note the source hedges with "probably", so this is a proposed rather than demonstrated substrate.
Multifocal Cortical Epileptogenicity with Age-Shifting Foci
Interictal EEG shows shifting or multiple spike foci rather than one stable epileptogenic zone. The distribution is itself age-dependent, running occipital in the youngest children, then occipital together with frontopolar, then centro-parieto-temporal, before disappearing altogether by adolescence. That migration is a fair summary of the syndrome: the excitable tissue moves as the brain matures, and then the excitability goes away.
Downstream
Focal Autonomic Seizures The route from a multifocal cortical discharge to a stereotyped emetic and autonomic seizure is not established, which is the substance of one of this entry's discussions, so the edge is indirect with unknown intermediates.
Show evidence (2 references)
PMID:16950946 SUPPORT Human Clinical
"An electroencephalogram is the only investigation with abnormal results, usually showing multiple spikes in various brain locations."
Establishes the multifocal EEG abnormality as the only positive investigation, which is the content of this node.
PMID:37660659 SUPPORT Other
"The interictal EEG characteristics of SeLEAS are multifocal EEG foci with age-dependent predominant locations; occipital (O) at 2-5 years old, and occipital and frontopolar (synchronous and independent O and Fp spikes) at 4-7 years old and centro-parieto-temporal (CPT) at 6-10 years old."
Gives the age-dependent migration of the foci in detail, which is the specific claim this node makes about how the abnormality changes with maturation.
Age-Specific Vulnerability of Central Autonomic Networks
The most distinctive and least explained part of the syndrome. The published account holds that ictal discharges produce autonomic disturbance and emesis irrespective of where they start, because the child's central autonomic networks are unusually susceptible to being recruited. That claim is doing a lot of work: it is what reconciles a multifocal, migrating EEG with a stereotyped emetic semiology, and it also explains why the same seizure sequence simply does not occur in adults. No cellular or circuit mechanism for the susceptibility is established.
Downstream
Focal Autonomic Seizures
Show evidence (2 references)
PMID:16950946 SUPPORT Other
"Ictal epileptic discharges in Panayiotopoulos syndrome, irrespective of their location at onset, activate autonomic disturbances and emesis, to which children are particularly vulnerable."
The core mechanistic claim of this node, including the explicit location-independence that makes it unusual among focal epilepsies.
PMID:16950946 SUPPORT Human Clinical
"The symptoms/sequence of autonomic seizures and autonomic status epilepticus in Panayiotopoulos syndrome are specific to childhood, and they do not occur in adults."
Supports the age-specificity of the vulnerability, which is why this node is framed as developmental rather than as a fixed anatomical property.
Focal Autonomic Seizures
Seizures composed predominantly of autonomic disturbance, with emesis the leading symptom, frequently accompanied by pallor and pupillary change and sometimes by incontinence, hypersalivation, or cardiorespiratory and thermoregulatory alteration. Awareness is often preserved at onset and lost later. Autonomic symptoms may be the entire seizure. Roughly half end in hemiconvulsions or generalized convulsions.
Downstream
Autonomic Status Epilepticus
Show evidence (2 references)
PMID:16950946 SUPPORT Human Clinical
"Autonomic seizures in Panayiotopoulos syndrome consist of episodes of disturbed autonomic function with emesis as the predominant symptom."
Defines the seizure type and names emesis as the leading manifestation.
PMID:16950946 SUPPORT Human Clinical
"Only half of the seizures end with brief hemiconvulsions or generalized convulsions. Convulsive status epilepticus is extremely rare."
Quantifies the convulsive evolution and records that convulsive status is rare, in contrast to the autonomic status that is common.
Autonomic Status Epilepticus
Half of the seizures run beyond thirty minutes, so autonomic status epilepticus is a defining feature rather than a complication. It is the commonest non-convulsive status epilepticus in otherwise normal children. It imparts no residual neurological deficit, which is the fact that most sharply separates it from the encephalitis it is mistaken for.
Downstream
Age-Dependent Remission
Show evidence (2 references)
PMID:16950946 SUPPORT Human Clinical
"Half of the seizures in Panayiotopoulos syndrome last for >30 minutes, thus constituting autonomic status epilepticus, which is the more common nonconvulsive status epilepticus in normal children."
Quantifies the proportion of prolonged seizures and establishes that autonomic status is characteristic of the syndrome.
PMID:16950946 SUPPORT Human Clinical
"Autonomic status epilepticus imparts no residual neurologic deficit."
Records the benign outcome of the prolonged seizures, which is what justifies conservative management despite their alarming appearance.
Age-Dependent Remission
Seizures are infrequent in most patients and remit within a few years of onset, and the EEG foci disappear by adolescence. The risk of epilepsy in adult life is not raised above the general population. This is the "self-limited" in the syndrome's name, and it is the reason the treatment section is so thin.
Show evidence (2 references)
PMID:16950946 SUPPORT Human Clinical
"The risk of epilepsy in adult life seems to be no higher than in the general population."
States the long-term outcome that defines the self-limited character of the syndrome.
PMID:37660659 SUPPORT Other
"O EEG foci evolve to multifocal EEG foci with a O-Fp or CPT predominance with age and disappear by 12∼16 years old."
Gives the electrographic counterpart of remission: the foci themselves disappear by adolescence.
⬡

Pathograph

Use the checkboxes to hide or show graph categories. Hover nodes for evidence and cross-linked metadata.
Pathograph: causal mechanism network for Self-Limited Epilepsy with Autonomic Seizures Interactive directed graph showing how pathophysiology mechanisms, phenotypes, genetic factors and variants, experimental models, environmental triggers, and treatments relate through causal and linked edges.
●

Phenotypes

10
Head and Neck 1
Ictal Hypersalivation Excessive salivation HP:0003781 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Ictal hypersalivation, annotated with Excessive salivation (HP:0003781). HP:0003781 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:16950946 SUPPORT Human Clinical
"incontinence of urine and/or feces, hypersalivation, and modifications of intestinal motility"
Names hypersalivation among the autonomic manifestations of the seizure.
Other 9
Ictal Vomiting VERY_FREQUENT Focal autonomic seizure with epigastric sensation/nausea/vomiting/other gastrointestinal phenomena HP:0011159 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Focal autonomic seizure with epigastric sensation/nausea/vomiting/other gastrointestinal phenomena (HP:0011159), qualified as childhood onset. HP:0011159 is a phenotype from the Human Phenotype Ontology.
Onset: CHILDHOOD
Show evidence (1 reference)
PMID:16950946 SUPPORT Human Clinical
"Autonomic seizures in Panayiotopoulos syndrome consist of episodes of disturbed autonomic function with emesis as the predominant symptom."
Establishes emesis as the predominant symptom, which is why this phenotype is VERY_FREQUENT and effectively definitional.
Ictal Pallor Focal autonomic seizure with pallor/flushing HP:0032762 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Focal autonomic seizure with pallor/flushing (HP:0032762). HP:0032762 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:16950946 SUPPORT Human Clinical
"Other autonomic manifestations include pallor (or, less often, flushing or cyanosis)"
Names pallor as an autonomic manifestation and records flushing and cyanosis as the less common alternatives.
Ictal Pupillary Change Focal autonomic seizure with pupillary dilation/constriction HP:0032763 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Focal autonomic seizure with pupillary dilation/constriction (HP:0032763). HP:0032763 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:16950946 SUPPORT Human Clinical
"mydriasis (or, less often, miosis), cardiorespiratory and thermoregulatory alterations, incontinence of urine and/or feces, hypersalivation, and modifications of intestinal motility"
Names the pupillary changes together with the rest of the autonomic constellation modelled in this entry.
Ictal Syncope OCCASIONAL Focal impaired awareness autonomic seizure HP:0032755 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Ictal syncope, annotated with Focal impaired awareness autonomic seizure (HP:0032755). HP:0032755 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:16950946 SUPPORT Human Clinical
"In approximately one fifth of the seizures the child becomes unresponsive and flaccid (ictal syncope) before or often without convulsions."
Quantifies ictal syncope at roughly one fifth of seizures, which falls in the 5 to 29 percent band mapping to OCCASIONAL.
Status Epilepticus FREQUENT HP:0002133 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Status epilepticus (HP:0002133). HP:0002133 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:16950946 SUPPORT Human Clinical
"Half of the seizures in Panayiotopoulos syndrome last for >30 minutes, thus constituting autonomic status epilepticus"
Quantifies prolonged seizures at half of all seizures, which falls in the 30 to 79 percent band mapping to FREQUENT.
Focal to Bilateral Tonic-Clonic Seizures FREQUENT Bilateral tonic-clonic seizure with focal onset HP:0007334 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Bilateral tonic-clonic seizure with focal onset (HP:0007334). HP:0007334 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:16950946 SUPPORT Human Clinical
"Only half of the seizures end with brief hemiconvulsions or generalized convulsions. Convulsive status epilepticus is extremely rare."
Quantifies convulsive evolution at half of seizures, which falls in the 30 to 79 percent band mapping to FREQUENT, and records that convulsive status is rare in contrast to the common autonomic status.
Ictal Incontinence Focal autonomic seizure with urge to urinate/defecate HP:0032765 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Ictal incontinence, annotated with Focal autonomic seizure with urge to urinate/defecate (HP:0032765). HP:0032765 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:16950946 SUPPORT Human Clinical
"incontinence of urine and/or feces, hypersalivation, and modifications of intestinal motility"
Names incontinence among the autonomic manifestations of the seizure.
Ictal Eye Deviation
Show evidence (1 reference)
PMID:16950946 SUPPORT Human Clinical
"Eyes turn to one side or gaze widely open."
States the ictal eye finding directly, in the sentence immediately following the loss of responsiveness, which is where it sits in the seizure sequence.
Impaired Awareness During Seizure Focal impaired awareness seizure HP:0002384 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Focal impaired awareness seizure (HP:0002384). HP:0002384 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:16950946 SUPPORT Human Clinical
"The child, who was initially fully conscious, becomes confused and unresponsive."
Documents the progression from preserved to impaired awareness within a single seizure, which is what this phenotype records.
💊

Medical Actions

3
Education and Conservative Management
Action: Supportive CareNCI Thesaurus (NCIT) Relation: this treatment is this clinical intervention This treatment is Supportive Care (NCIT:C15747). NCIT:C15747 is a clinical intervention from the NCI Thesaurus. NCIT:C15747
Because seizures are infrequent and the syndrome remits, the primary intervention is not a drug. Educating the family about what an autonomic seizure looks like, and about the fact that a prolonged episode leaves no deficit, is the stated cornerstone of management and is what prevents the cycle of emergency presentation, misdiagnosis, and unnecessary investigation that this syndrome otherwise generates.
Show evidence (3 references)
PMID:16950946 SUPPORT Other
"Education about Panayiotopoulos syndrome is the cornerstone of management."
States that education is the cornerstone of management for this syndrome, which is why it is curated as the primary intervention.
PMID:16950946 SUPPORT Human Clinical
"The consequence is avoidable misdiagnosis, high morbidity, and costly mismanagement."
Records the cost of failing to recognize the syndrome, which is the harm that education is intended to prevent.
PMID:16950946 SUPPORT Other
"Prophylactic treatment with antiepileptic medication may not be needed for most patients."
The management recommendation that follows from the benign course and low seizure frequency, and the reason no antiseizure medication is curated as a primary treatment in this entry.
Benzodiazepine Rescue for Autonomic Status Epilepticus
Action: PharmacotherapyNCI Thesaurus (NCIT) Relation: this treatment is this clinical intervention This treatment is Pharmacotherapy (NCIT:C15986). NCIT:C15986 is a clinical intervention from the NCI Thesaurus. NCIT:C15986
Agent: midazolam CHEBI:6931 Chemical Entities of Biological Interest (CHEBI) Relation: this treatment uses this therapeutic agent This treatment uses midazolam (CHEBI:6931). CHEBI:6931 is a therapeutic agent from Chemical Entities of Biological Interest.
What to do acutely, as the counterpart to the avoidance entry below. Seizures in this syndrome are unusually benzodiazepine-responsive: in an emergency-department comparison, every patient with the syndrome was controlled by a small dose of midazolam at 0.1 mg/kg, whereas every patient with acute encephalopathy required at least three times that. So the same observation is simultaneously the treatment and a diagnostic discriminator, and a child who needs escalating doses should prompt reconsideration of the diagnosis rather than more drug. This does not contradict the conservative posture of this entry. Most seizures need no acute treatment at all and prophylaxis is usually unnecessary; the point is that when a prolonged episode does warrant intervention, a small benzodiazepine dose is what is indicated, and escalation beyond it is where the iatrogenic risk recorded below begins.
Mechanism Target:
INHIBITS Autonomic Status Epilepticus — Terminates the prolonged seizure. It acts on seizure expression, not on the maturational susceptibility upstream, which is why it is a rescue measure rather than a disease-modifying one.
Show evidence (1 reference)
PMID:35153087 SUPPORT Human Clinical
"In addition, seizures were treatable in all patients with PS with a small dose of midazolam (0.1 mg/kg), but all patients with acute encephalopathy required midazolam at 0.3 mg/kg or more (P < 0.001)."
The one quantitatively supported acute-treatment finding for this syndrome, and simultaneously a diagnostic discriminator: complete response at 0.1 mg/kg in every case, against a threefold-or-greater requirement in the condition it is mistaken for.
Avoidance of Aggressive Acute Treatment
Action: Supportive CareNCI Thesaurus (NCIT) Relation: this treatment is this clinical intervention This treatment is Supportive Care (NCIT:C15747). NCIT:C15747 is a clinical intervention from the NCI Thesaurus. NCIT:C15747
A treatment entry recording what not to do. Autonomic status epilepticus here is alarming and prolonged, and it invites escalation, but the source is explicit that aggressive treatment may itself cause iatrogenic complications including cardiorespiratory arrest. This is a distinct hazard from the seizure-intrinsic cardiorespiratory risk recorded in the self-limited-label discussion: here the harm comes from the response rather than from the event. Because the prolonged episode leaves no residual deficit, the risk-benefit calculation favours thorough evaluation over aggressive intervention.
Show evidence (2 references)
PMID:16950946 SUPPORT Other
"Autonomic status epilepticus in the acute stage needs thorough evaluation; aggressive treatment may cause iatrogenic complications including cardiorespiratory arrest."
States both halves of the recommendation: the acute episode warrants thorough evaluation, and aggressive treatment carries its own risk of cardiorespiratory arrest.
PMID:16950946 SUPPORT Human Clinical
"Autonomic status epilepticus imparts no residual neurologic deficit."
The outcome fact that makes conservative management defensible: there is no deficit to prevent by escalating.
🔬

Diagnosis

1
Electroencephalography
EEG is the only investigation that returns an abnormal result, and it is therefore the diagnostic test. It typically shows multiple spikes in various locations, with a distribution that depends on the child's age. Imaging is normal.
Electroencephalography NCIT:C38054 NCI Thesaurus (NCIT)
Results: Shifting or multiple spike foci, occipital-predominant in younger children and migrating to frontopolar and centro-parieto-temporal distributions with age.
Show evidence (1 reference)
PMID:16950946 SUPPORT Human Clinical
"An electroencephalogram is the only investigation with abnormal results, usually showing multiple spikes in various brain locations."
Establishes EEG as the sole informative investigation and describes the expected finding.
📈

Progression

2
Onset in early to mid childhood
Age: Early and mid childhood
Onset is in early to mid childhood, with the occipital EEG focus predominating in the youngest children. Two thirds of seizures occur during sleep, which is part of why episodes are witnessed as a child waking vomiting and pale.
Show evidence (1 reference)
PMID:16950946 SUPPORT Human Clinical
"Two thirds of seizures occur during sleep."
Documents the sleep predominance that characterizes the presentation in this phase.
Remission within a few years
Age: Later childhood to adolescence
Seizures are infrequent and remit within a few years of onset. The EEG foci migrate through occipital, frontopolar, and centro-parieto-temporal distributions before disappearing by adolescence, and adult epilepsy risk returns to population baseline.
Show evidence (1 reference)
PMID:16950946 SUPPORT Human Clinical
"Panayiotopoulos syndrome is remarkably benign in terms of seizure frequency and evolution."
States the benign evolution that defines this phase.
📊

Prevalence

1
Children aged 3 to 6 years with one or more afebrile seizures
Unknown Unknown
The available figure is a share of an already-selected clinical population rather than a population rate: roughly 13 percent of children aged 3 to 6 who have had at least one afebrile seizure, and 6 percent across the 1 to 15 year range. No rate_per_100000 is asserted because the denominator is children with seizures, not children.
Show evidence (1 reference)
PMID:16950946 SUPPORT Human Clinical
"Panayiotopoulos syndrome probably affects 13% of children aged 3 to 6 years who have had 1 or more afebrile seizures and 6% of such children in the 1- to 15-year age group."
Gives both share figures and their denominators, which is why this record is expressed as a class rather than a normalized rate.
🔀

Differential Diagnoses

4

Conditions with similar clinical presentations that must be differentiated from Self-Limited Epilepsy with Autonomic Seizures:

Acute Encephalopathy or Encephalitis
Overlapping Features The most consequential differential and the reason these children reach an emergency department. Prolonged unresponsiveness with vomiting in a young child reads as encephalitis. A comparison of emergency presentations found the discriminator is convulsion duration: 90 percent of acute encephalopathy patients had convulsive seizures of at least 15 minutes, against 17 percent of this syndrome.
Distinguishing Features
  • Convulsive seizures of at least 15 minutes are typical of acute encephalopathy and unusual here.
  • Seizures here are controlled by midazolam at 0.1 mg/kg; acute encephalopathy needs at least threefold more.
  • No residual neurological deficit follows the prolonged episode.
Show evidence (2 references)
PMID:35153087 SUPPORT Human Clinical
"Most patients (90%) with acute encephalopathy had convulsive seizures of greater than or equal to 15 min, whereas only three patients (17%) with PS had convulsive seizures of greater than or equal to 15 min"
Provides a quantified bedside discriminator between the two conditions in the setting where the distinction actually has to be made.
PMID:35153087 SUPPORT Human Clinical
"In addition, seizures were treatable in all patients with PS with a small dose of midazolam (0.1 mg/kg), but all patients with acute encephalopathy required midazolam at 0.3 mg/kg or more (P < 0.001)."
Backs the treatability bullet in distinguishing_features, which previously stood unsupported in this block. Drug responsiveness is a second discriminator independent of convulsion duration, and a useful one because it declares itself within minutes of the first dose rather than requiring the episode to run its course.
Cyclic Vomiting Syndrome
Overlapping Features Separated from the other non-epileptic mimics because it is the hardest of them to exclude clinically. Both conditions produce recurrent, stereotyped, prolonged vomiting episodes in a child who is well between attacks, and both can involve pallor and lethargy. The distinction rests on the accompanying features and on the EEG rather than on the vomiting itself.
Distinguishing Features
  • Pupillary change, eye deviation, and impaired awareness accompany the vomiting in the epilepsy.
  • Interictal EEG shows multifocal spikes, whereas it is normal in cyclic vomiting syndrome.
  • Two thirds of episodes arise from sleep in the epilepsy.
  • Episodes can end in hemiconvulsions or generalized convulsions in the epilepsy.
Show evidence (1 reference)
PMID:16950946 SUPPORT Human Clinical
"The clinical features of Panayiotopoulos syndrome are frequently mistaken as nonepileptic conditions such as acute encephalitis, syncope, migraine, cyclic vomiting syndrome, motion sickness, sleep disorder, or gastroenteritis."
Names cyclic vomiting syndrome specifically among the conditions this syndrome is mistaken for.
Gastroenteritis, Migraine, Syncope, and Motion Sickness
Overlapping Features The remaining non-epileptic mimics. Grouped because they share the feature that matters here: none is epilepsy, and each sends the child down a different and unnecessary diagnostic path. Cyclic vomiting syndrome is listed separately above because it is materially harder to exclude.
Distinguishing Features
  • Stereotyped episodes with a consistent autonomic sequence rather than variable illness.
  • Accompanying pallor, pupillary change, and eye deviation.
  • Abnormal interictal EEG with multifocal spikes.
Show evidence (1 reference)
PMID:16950946 SUPPORT Human Clinical
"The clinical features of Panayiotopoulos syndrome are frequently mistaken as nonepileptic conditions such as acute encephalitis, syncope, migraine, cyclic vomiting syndrome, motion sickness, sleep disorder, or gastroenteritis."
Enumerates the non-epileptic conditions this syndrome imitates, which is the content of this grouped differential.
Self-Limited Epilepsy with Centrotemporal Spikes
Overlapping Features The sibling syndrome, and on the leading account the late-onset phenotype of the same maturational susceptibility. Distinguished by later onset and by orofacial and speech-arrest semiology rather than autonomic symptoms. The two can occur in the same patient. dismech carries a separate entry.
Distinguishing Features
  • Later onset in mid to late childhood.
  • Orofacial sensorimotor seizures with speech arrest and hypersalivation rather than emesis.
  • Centrotemporal spikes rather than shifting occipital-predominant foci.
Show evidence (1 reference)
PMID:16950946 SUPPORT Other
"Panayiotopoulos syndrome is probably the early-onset and Rolandic epilepsy the late-onset phenotype of a maturation-related benign childhood seizure-susceptibility syndrome."
Supports the proposed relationship between the two syndromes. Marked PARTIAL because the source hedges the unification and the statement is a proposal rather than a demonstrated identity.
{ }

Source YAML

click to show 
name: Self-Limited Epilepsy with Autonomic Seizures
creation_date: "2026-08-05T00:00:00Z"
category: Complex
description: >-
  Self-limited epilepsy with autonomic seizures, long known as Panayiotopoulos
  syndrome, is a childhood focal epilepsy whose seizures are made almost entirely
  of autonomic symptoms. The child typically retains awareness at onset while
  going pale and vomiting repeatedly, and the episode commonly runs past thirty
  minutes, which makes autonomic status epilepticus the rule rather than a
  complication. Two thirds of seizures happen in sleep. The EEG shows shifting
  multifocal spikes, classically occipital in the youngest children but migrating
  with age. Seizures are usually few, remission within a few years is the norm,
  and the adult epilepsy risk is not raised above the population. The clinical
  problem is not the epilepsy but the mimicry: prolonged vomiting with altered
  responsiveness in a young child is routinely mistaken for encephalitis,
  gastroenteritis, migraine, or syncope.
parents:
  - Epilepsy
  - Neurological Disease
synonyms:
  - SeLEAS
  - Panayiotopoulos syndrome
  - early-onset benign childhood occipital epilepsy
  - benign childhood autonomic epilepsy
disease_term:
  preferred_term: self-limited epilepsy with autonomic seizures
  term:
    id: MONDO:0020307
    label: self-limited epilepsy with autonomic seizures
mappings:
  mondo_mappings:
    - term:
        id: MONDO:0020307
        label: self-limited epilepsy with autonomic seizures
      mapping_predicate: skos:exactMatch
      mapping_source: MONDO
      mapping_justification: >-
        MONDO:0020307 is the self-limited epilepsy with autonomic seizures
        concept, the ILAE 2022 name for what was previously called
        Panayiotopoulos syndrome.
references:
  - reference: PMID:16950946
    title: >-
      Panayiotopoulos syndrome: a benign childhood autonomic epilepsy frequently
      imitating encephalitis, syncope, migraine, sleep disorder, or
      gastroenteritis.
  - reference: PMID:35503717
    title: >-
      International League Against Epilepsy classification and definition of
      epilepsy syndromes with onset in childhood: Position paper by the ILAE Task
      Force on Nosology and Definitions.
notes: >-
  Naming note. The ILAE 2022 childhood-syndromes position paper renamed this
  syndrome from Panayiotopoulos syndrome to self-limited epilepsy with autonomic
  seizures, as part of a general shift toward names that describe seizure
  semiology. The change is substantive rather than cosmetic: the older label
  "early-onset benign childhood occipital epilepsy" asserted an occipital
  localization that the EEG literature no longer supports as definitional, and
  the current name commits instead to the autonomic semiology. This entry uses
  the current name and keeps the historical ones as synonyms.

  Scope note. This entry does not curate a genetic section. No causative gene is
  established for this syndrome, and the mechanism as described in the source
  literature is maturational rather than monogenic; asserting candidate genes
  here would overstate what is known.
pathophysiology:
  - name: Maturational Seizure Susceptibility of the Developing Brain
    biological_scale: ORGANISM
    description: >-
      The proposed substrate is not a lesion but a developmental window. The
      leading account treats this syndrome and self-limited epilepsy with
      centrotemporal spikes as the early-onset and late-onset phenotypes of one
      maturation-related childhood seizure-susceptibility state, which is why
      both remit and why neither leaves a deficit. Nothing structural is
      demonstrable, and the syndrome's boundaries are set by age rather than by
      anatomy.
    downstream:
      - target: Multifocal Cortical Epileptogenicity with Age-Shifting Foci
        causal_link_type: DIRECT
      - target: Age-Specific Vulnerability of Central Autonomic Networks
        causal_link_type: DIRECT
        evidence:
          - reference: PMID:16950946
            reference_title: >-
              Panayiotopoulos syndrome: a benign childhood autonomic epilepsy
              frequently imitating encephalitis, syncope, migraine, sleep
              disorder, or gastroenteritis.
            supports: SUPPORT
            evidence_source: HUMAN_CLINICAL
            snippet: >-
              The symptoms/sequence of autonomic seizures and autonomic status
              epilepticus in Panayiotopoulos syndrome are specific to childhood,
              and they do not occur in adults.
            explanation: >-
              Ties the autonomic vulnerability to the childhood developmental
              window, which is what makes it a consequence of the maturational
              state rather than an independent property.
    evidence:
      - reference: PMID:16950946
        reference_title: >-
          Panayiotopoulos syndrome: a benign childhood autonomic epilepsy
          frequently imitating encephalitis, syncope, migraine, sleep disorder,
          or gastroenteritis.
        supports: SUPPORT
        evidence_source: OTHER
        snippet: >-
          Panayiotopoulos syndrome is probably the early-onset and Rolandic
          epilepsy the late-onset phenotype of a maturation-related benign
          childhood seizure-susceptibility syndrome.
        explanation: >-
          States the maturational-susceptibility account and its relationship to
          the centrotemporal-spike syndrome, which is exactly what this node
          asserts. Note the source hedges with "probably", so this is a proposed
          rather than demonstrated substrate.
  - name: Multifocal Cortical Epileptogenicity with Age-Shifting Foci
    biological_scale: TISSUE
    conforms_to: "epilepsy_excitation_inhibition_imbalance#Neuronal Hyperexcitability and Hypersynchrony"
    description: >-
      Interictal EEG shows shifting or multiple spike foci rather than one stable
      epileptogenic zone. The distribution is itself age-dependent, running
      occipital in the youngest children, then occipital together with
      frontopolar, then centro-parieto-temporal, before disappearing altogether
      by adolescence. That migration is a fair summary of the syndrome: the
      excitable tissue moves as the brain matures, and then the excitability goes
      away.
    downstream:
      - target: Focal Autonomic Seizures
        causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
        description: >-
          The route from a multifocal cortical discharge to a stereotyped emetic
          and autonomic seizure is not established, which is the substance of one
          of this entry's discussions, so the edge is indirect with unknown
          intermediates.
    evidence:
      - reference: PMID:16950946
        reference_title: >-
          Panayiotopoulos syndrome: a benign childhood autonomic epilepsy
          frequently imitating encephalitis, syncope, migraine, sleep disorder,
          or gastroenteritis.
        supports: SUPPORT
        evidence_source: HUMAN_CLINICAL
        snippet: >-
          An electroencephalogram is the only investigation with abnormal
          results, usually showing multiple spikes in various brain locations.
        explanation: >-
          Establishes the multifocal EEG abnormality as the only positive
          investigation, which is the content of this node.
      - reference: PMID:37660659
        reference_title: >-
          A reappraisal of interictal EEG characteristics in self-limited
          epilepsy with autonomic seizures, formerly known as Panayiotopoulos
          syndrome or early-onset benign occipital epilepsy.
        supports: SUPPORT
        evidence_source: OTHER
        snippet: >-
          The interictal EEG characteristics of SeLEAS are multifocal EEG foci
          with age-dependent predominant locations; occipital (O) at 2-5 years
          old, and occipital and frontopolar (synchronous and independent O and
          Fp spikes) at 4-7 years old and centro-parieto-temporal (CPT) at 6-10
          years old.
        explanation: >-
          Gives the age-dependent migration of the foci in detail, which is the
          specific claim this node makes about how the abnormality changes with
          maturation.
  - name: Age-Specific Vulnerability of Central Autonomic Networks
    biological_scale: TISSUE
    description: >-
      The most distinctive and least explained part of the syndrome. The
      published account holds that ictal discharges produce autonomic
      disturbance and emesis irrespective of where they start, because the
      child's central autonomic networks are unusually susceptible to being
      recruited. That claim is doing a lot of work: it is what reconciles a
      multifocal, migrating EEG with a stereotyped emetic semiology, and it also
      explains why the same seizure sequence simply does not occur in adults.
      No cellular or circuit mechanism for the susceptibility is established.
    downstream:
      - target: Focal Autonomic Seizures
        causal_link_type: DIRECT
    evidence:
      - reference: PMID:16950946
        reference_title: >-
          Panayiotopoulos syndrome: a benign childhood autonomic epilepsy
          frequently imitating encephalitis, syncope, migraine, sleep disorder,
          or gastroenteritis.
        supports: SUPPORT
        evidence_source: OTHER
        snippet: >-
          Ictal epileptic discharges in Panayiotopoulos syndrome, irrespective of
          their location at onset, activate autonomic disturbances and emesis, to
          which children are particularly vulnerable.
        explanation: >-
          The core mechanistic claim of this node, including the explicit
          location-independence that makes it unusual among focal epilepsies.
      - reference: PMID:16950946
        reference_title: >-
          Panayiotopoulos syndrome: a benign childhood autonomic epilepsy
          frequently imitating encephalitis, syncope, migraine, sleep disorder,
          or gastroenteritis.
        supports: SUPPORT
        evidence_source: HUMAN_CLINICAL
        snippet: >-
          The symptoms/sequence of autonomic seizures and autonomic status
          epilepticus in Panayiotopoulos syndrome are specific to childhood, and
          they do not occur in adults.
        explanation: >-
          Supports the age-specificity of the vulnerability, which is why this
          node is framed as developmental rather than as a fixed anatomical
          property.
  - name: Focal Autonomic Seizures
    biological_scale: ORGANISM
    conforms_to: "epilepsy_excitation_inhibition_imbalance#Recurrent Unprovoked Seizures"
    description: >-
      Seizures composed predominantly of autonomic disturbance, with emesis the
      leading symptom, frequently accompanied by pallor and pupillary change and
      sometimes by incontinence, hypersalivation, or cardiorespiratory and
      thermoregulatory alteration. Awareness is often preserved at onset and lost
      later. Autonomic symptoms may be the entire seizure. Roughly half end in
      hemiconvulsions or generalized convulsions.
    downstream:
      - target: Autonomic Status Epilepticus
        causal_link_type: DIRECT
        evidence:
          - reference: PMID:16950946
            reference_title: >-
              Panayiotopoulos syndrome: a benign childhood autonomic epilepsy
              frequently imitating encephalitis, syncope, migraine, sleep
              disorder, or gastroenteritis.
            supports: SUPPORT
            evidence_source: HUMAN_CLINICAL
            snippet: >-
              Half of the seizures in Panayiotopoulos syndrome last for >30
              minutes, thus constituting autonomic status epilepticus
            explanation: >-
              Establishes that autonomic status is simply what happens when an
              autonomic seizure runs long, which is this edge: the status is a
              duration property of the seizure rather than a separate event.
    evidence:
      - reference: PMID:16950946
        reference_title: >-
          Panayiotopoulos syndrome: a benign childhood autonomic epilepsy
          frequently imitating encephalitis, syncope, migraine, sleep disorder,
          or gastroenteritis.
        supports: SUPPORT
        evidence_source: HUMAN_CLINICAL
        snippet: >-
          Autonomic seizures in Panayiotopoulos syndrome consist of episodes of
          disturbed autonomic function with emesis as the predominant symptom.
        explanation: >-
          Defines the seizure type and names emesis as the leading manifestation.
      - reference: PMID:16950946
        reference_title: >-
          Panayiotopoulos syndrome: a benign childhood autonomic epilepsy
          frequently imitating encephalitis, syncope, migraine, sleep disorder,
          or gastroenteritis.
        supports: SUPPORT
        evidence_source: HUMAN_CLINICAL
        snippet: >-
          Only half of the seizures end with brief hemiconvulsions or generalized
          convulsions. Convulsive status epilepticus is extremely rare.
        explanation: >-
          Quantifies the convulsive evolution and records that convulsive status
          is rare, in contrast to the autonomic status that is common.
  - name: Autonomic Status Epilepticus
    biological_scale: ORGANISM
    description: >-
      Half of the seizures run beyond thirty minutes, so autonomic status
      epilepticus is a defining feature rather than a complication. It is the
      commonest non-convulsive status epilepticus in otherwise normal children.
      It imparts no residual neurological deficit, which is the fact that most
      sharply separates it from the encephalitis it is mistaken for.
    downstream:
      - target: Age-Dependent Remission
        causal_link_type: DIRECT
        evidence:
          - reference: PMID:16950946
            reference_title: >-
              Panayiotopoulos syndrome: a benign childhood autonomic epilepsy
              frequently imitating encephalitis, syncope, migraine, sleep
              disorder, or gastroenteritis.
            supports: SUPPORT
            evidence_source: HUMAN_CLINICAL
            snippet: >-
              Autonomic status epilepticus imparts no residual neurologic
              deficit.
            explanation: >-
              Supports the edge from prolonged seizures to an intact outcome:
              status here does not derail the remission trajectory, which is what
              distinguishes this syndrome from the encephalopathies it mimics.
    evidence:
      - reference: PMID:16950946
        reference_title: >-
          Panayiotopoulos syndrome: a benign childhood autonomic epilepsy
          frequently imitating encephalitis, syncope, migraine, sleep disorder,
          or gastroenteritis.
        supports: SUPPORT
        evidence_source: HUMAN_CLINICAL
        snippet: >-
          Half of the seizures in Panayiotopoulos syndrome last for >30 minutes,
          thus constituting autonomic status epilepticus, which is the more
          common nonconvulsive status epilepticus in normal children.
        explanation: >-
          Quantifies the proportion of prolonged seizures and establishes that
          autonomic status is characteristic of the syndrome.
      - reference: PMID:16950946
        reference_title: >-
          Panayiotopoulos syndrome: a benign childhood autonomic epilepsy
          frequently imitating encephalitis, syncope, migraine, sleep disorder,
          or gastroenteritis.
        supports: SUPPORT
        evidence_source: HUMAN_CLINICAL
        snippet: >-
          Autonomic status epilepticus imparts no residual neurologic deficit.
        explanation: >-
          Records the benign outcome of the prolonged seizures, which is what
          justifies conservative management despite their alarming appearance.
  - name: Age-Dependent Remission
    biological_scale: ORGANISM
    description: >-
      Seizures are infrequent in most patients and remit within a few years of
      onset, and the EEG foci disappear by adolescence. The risk of epilepsy in
      adult life is not raised above the general population. This is the
      "self-limited" in the syndrome's name, and it is the reason the treatment
      section is so thin.
    evidence:
      - reference: PMID:16950946
        reference_title: >-
          Panayiotopoulos syndrome: a benign childhood autonomic epilepsy
          frequently imitating encephalitis, syncope, migraine, sleep disorder,
          or gastroenteritis.
        supports: SUPPORT
        evidence_source: HUMAN_CLINICAL
        snippet: >-
          The risk of epilepsy in adult life seems to be no higher than in the
          general population.
        explanation: >-
          States the long-term outcome that defines the self-limited character of
          the syndrome.
      - reference: PMID:37660659
        reference_title: >-
          A reappraisal of interictal EEG characteristics in self-limited
          epilepsy with autonomic seizures, formerly known as Panayiotopoulos
          syndrome or early-onset benign occipital epilepsy.
        supports: SUPPORT
        evidence_source: OTHER
        snippet: >-
          O EEG foci evolve to multifocal EEG foci with a O-Fp or CPT
          predominance with age and disappear by 12∼16 years old.
        explanation: >-
          Gives the electrographic counterpart of remission: the foci themselves
          disappear by adolescence.
phenotypes:
  - name: Ictal Vomiting
    category: Neurologic
    description: >-
      Emesis is the cardinal and most characteristic manifestation. The child is
      typically fully conscious when it starts, which is part of why the episode
      reads as gastroenteritis rather than as a seizure.
    phenotype_term:
      preferred_term: >-
        Focal autonomic seizure with epigastric sensation/nausea/vomiting/other
        gastrointestinal phenomena
      term:
        id: HP:0011159
        label: >-
          Focal autonomic seizure with epigastric sensation/nausea/vomiting/other
          gastrointestinal phenomena
      onset:
        onset_category: CHILDHOOD
    frequency: VERY_FREQUENT
    evidence:
      - reference: PMID:16950946
        reference_title: >-
          Panayiotopoulos syndrome: a benign childhood autonomic epilepsy
          frequently imitating encephalitis, syncope, migraine, sleep disorder,
          or gastroenteritis.
        supports: SUPPORT
        evidence_source: HUMAN_CLINICAL
        snippet: >-
          Autonomic seizures in Panayiotopoulos syndrome consist of episodes of
          disturbed autonomic function with emesis as the predominant symptom.
        explanation: >-
          Establishes emesis as the predominant symptom, which is why this
          phenotype is VERY_FREQUENT and effectively definitional.
  - name: Ictal Pallor
    category: Neurologic
    description: >-
      Pallor accompanies the emesis in most seizures; flushing or cyanosis occur
      less often. Together with vomiting it produces the picture that is
      routinely read as a faint or an acute illness.
    phenotype_term:
      preferred_term: Focal autonomic seizure with pallor/flushing
      term:
        id: HP:0032762
        label: Focal autonomic seizure with pallor/flushing
    evidence:
      - reference: PMID:16950946
        reference_title: >-
          Panayiotopoulos syndrome: a benign childhood autonomic epilepsy
          frequently imitating encephalitis, syncope, migraine, sleep disorder,
          or gastroenteritis.
        supports: SUPPORT
        evidence_source: HUMAN_CLINICAL
        snippet: >-
          Other autonomic manifestations include pallor (or, less often, flushing
          or cyanosis)
        explanation: >-
          Names pallor as an autonomic manifestation and records flushing and
          cyanosis as the less common alternatives.
  - name: Ictal Pupillary Change
    category: Neurologic
    description: >-
      Mydriasis, less often miosis, is part of the autonomic constellation and is
      one of the signs that can distinguish an autonomic seizure from a
      gastrointestinal illness at the bedside.
    phenotype_term:
      preferred_term: Focal autonomic seizure with pupillary dilation/constriction
      term:
        id: HP:0032763
        label: Focal autonomic seizure with pupillary dilation/constriction
    evidence:
      - reference: PMID:16950946
        reference_title: >-
          Panayiotopoulos syndrome: a benign childhood autonomic epilepsy
          frequently imitating encephalitis, syncope, migraine, sleep disorder,
          or gastroenteritis.
        supports: SUPPORT
        evidence_source: HUMAN_CLINICAL
        snippet: >-
          mydriasis (or, less often, miosis), cardiorespiratory and
          thermoregulatory alterations, incontinence of urine and/or feces,
          hypersalivation, and modifications of intestinal motility
        explanation: >-
          Names the pupillary changes together with the rest of the autonomic
          constellation modelled in this entry.
  - name: Ictal Syncope
    category: Neurologic
    description: >-
      In about one fifth of seizures the child becomes unresponsive and flaccid,
      before or entirely without convulsions. This is the presentation most
      likely to be recorded as a faint, and it is a major contributor to the
      syndrome's misdiagnosis rate.
    phenotype_term:
      preferred_term: Ictal syncope
      term:
        id: HP:0032755
        label: Focal impaired awareness autonomic seizure
    frequency: OCCASIONAL
    evidence:
      - reference: PMID:16950946
        reference_title: >-
          Panayiotopoulos syndrome: a benign childhood autonomic epilepsy
          frequently imitating encephalitis, syncope, migraine, sleep disorder,
          or gastroenteritis.
        supports: SUPPORT
        evidence_source: HUMAN_CLINICAL
        snippet: >-
          In approximately one fifth of the seizures the child becomes
          unresponsive and flaccid (ictal syncope) before or often without
          convulsions.
        explanation: >-
          Quantifies ictal syncope at roughly one fifth of seizures, which falls
          in the 5 to 29 percent band mapping to OCCASIONAL.
  - name: Status Epilepticus
    category: Neurologic
    description: >-
      Prolonged seizures lasting more than thirty minutes, constituting autonomic
      status epilepticus. This is characteristic rather than exceptional in this
      syndrome, occurring in about half of all seizures.
    phenotype_term:
      preferred_term: Status epilepticus
      term:
        id: HP:0002133
        label: Status epilepticus
    frequency: FREQUENT
    evidence:
      - reference: PMID:16950946
        reference_title: >-
          Panayiotopoulos syndrome: a benign childhood autonomic epilepsy
          frequently imitating encephalitis, syncope, migraine, sleep disorder,
          or gastroenteritis.
        supports: SUPPORT
        evidence_source: HUMAN_CLINICAL
        snippet: >-
          Half of the seizures in Panayiotopoulos syndrome last for >30 minutes,
          thus constituting autonomic status epilepticus
        explanation: >-
          Quantifies prolonged seizures at half of all seizures, which falls in
          the 30 to 79 percent band mapping to FREQUENT.
  - name: Focal to Bilateral Tonic-Clonic Seizures
    category: Neurologic
    description: >-
      About half of seizures end in brief hemiconvulsions or generalized
      convulsions. This is the point at which a family recognizes the episode as
      a seizure rather than an illness, and it is also the feature that most
      often prompts emergency presentation.
    phenotype_term:
      preferred_term: Bilateral tonic-clonic seizure with focal onset
      term:
        id: HP:0007334
        label: Bilateral tonic-clonic seizure with focal onset
    frequency: FREQUENT
    evidence:
      - reference: PMID:16950946
        reference_title: >-
          Panayiotopoulos syndrome: a benign childhood autonomic epilepsy
          frequently imitating encephalitis, syncope, migraine, sleep disorder,
          or gastroenteritis.
        supports: SUPPORT
        evidence_source: HUMAN_CLINICAL
        snippet: >-
          Only half of the seizures end with brief hemiconvulsions or generalized
          convulsions. Convulsive status epilepticus is extremely rare.
        explanation: >-
          Quantifies convulsive evolution at half of seizures, which falls in the
          30 to 79 percent band mapping to FREQUENT, and records that convulsive
          status is rare in contrast to the common autonomic status.
  - name: Ictal Incontinence
    category: Neurologic
    description: >-
      Loss of bladder or bowel control during the seizure, part of the wider
      autonomic constellation rather than a marker of severity.
    phenotype_term:
      preferred_term: Ictal incontinence
      term:
        id: HP:0032765
        label: Focal autonomic seizure with urge to urinate/defecate
    evidence:
      - reference: PMID:16950946
        reference_title: >-
          Panayiotopoulos syndrome: a benign childhood autonomic epilepsy
          frequently imitating encephalitis, syncope, migraine, sleep disorder,
          or gastroenteritis.
        supports: SUPPORT
        evidence_source: HUMAN_CLINICAL
        snippet: >-
          incontinence of urine and/or feces, hypersalivation, and modifications
          of intestinal motility
        explanation: >-
          Names incontinence among the autonomic manifestations of the seizure.
  - name: Ictal Hypersalivation
    category: Neurologic
    description: >-
      Excessive salivation during the seizure, another autonomic feature and one
      shared with the sibling centrotemporal-spike syndrome.
    phenotype_term:
      preferred_term: Ictal hypersalivation
      term:
        id: HP:0003781
        label: Excessive salivation
    evidence:
      - reference: PMID:16950946
        reference_title: >-
          Panayiotopoulos syndrome: a benign childhood autonomic epilepsy
          frequently imitating encephalitis, syncope, migraine, sleep disorder,
          or gastroenteritis.
        supports: SUPPORT
        evidence_source: HUMAN_CLINICAL
        snippet: >-
          incontinence of urine and/or feces, hypersalivation, and modifications
          of intestinal motility
        explanation: >-
          Names hypersalivation among the autonomic manifestations of the
          seizure.
  - name: Ictal Eye Deviation
    category: Neurologic
    description: >-
      The eyes turn to one side, or open wide and stare, as awareness is lost.
      Together with emesis and impaired responsiveness this completes the triad
      that has defined the syndrome since its original description, and it is
      often the feature a parent recalls most vividly.

      No term is bound here. The obvious HPO candidate, HP:0000549 Abnormal
      conjugate eye movement, is defined as deviation from the normal
      coordination that lets the eyes fixate together, with "disconjugate eye
      movements" as an exact synonym. Ictal deviation is the opposite: the eyes
      move together, conjugately, to one side. Binding it would assert the wrong
      thing, in the same way the earlier HP:0001279 syncope binding did, so the
      phenotype is recorded with free text pending a suitable term.
    phenotype_term:
      preferred_term: Ictal conjugate eye deviation
    evidence:
      - reference: PMID:16950946
        reference_title: >-
          Panayiotopoulos syndrome: a benign childhood autonomic epilepsy
          frequently imitating encephalitis, syncope, migraine, sleep disorder,
          or gastroenteritis.
        supports: SUPPORT
        evidence_source: HUMAN_CLINICAL
        snippet: >-
          Eyes turn to one side or gaze widely open.
        explanation: >-
          States the ictal eye finding directly, in the sentence immediately
          following the loss of responsiveness, which is where it sits in the
          seizure sequence.
  - name: Impaired Awareness During Seizure
    category: Neurologic
    description: >-
      Awareness is characteristically preserved at seizure onset and lost as the
      episode proceeds, with the child becoming confused and unresponsive and the
      eyes deviating or opening widely. That temporal sequence, autonomic first
      and awareness second, is diagnostically useful.
    phenotype_term:
      preferred_term: Focal impaired awareness seizure
      term:
        id: HP:0002384
        label: Focal impaired awareness seizure
    evidence:
      - reference: PMID:16950946
        reference_title: >-
          Panayiotopoulos syndrome: a benign childhood autonomic epilepsy
          frequently imitating encephalitis, syncope, migraine, sleep disorder,
          or gastroenteritis.
        supports: SUPPORT
        evidence_source: HUMAN_CLINICAL
        snippet: >-
          The child, who was initially fully conscious, becomes confused and
          unresponsive.
        explanation: >-
          Documents the progression from preserved to impaired awareness within a
          single seizure, which is what this phenotype records.
prevalence:
  - population: Children aged 3 to 6 years with one or more afebrile seizures
    measure_type: UNKNOWN
    prevalence_class: UNKNOWN
    notes: >-
      The available figure is a share of an already-selected clinical population
      rather than a population rate: roughly 13 percent of children aged 3 to 6
      who have had at least one afebrile seizure, and 6 percent across the 1 to
      15 year range. No rate_per_100000 is asserted because the denominator is
      children with seizures, not children.
    evidence:
      - reference: PMID:16950946
        reference_title: >-
          Panayiotopoulos syndrome: a benign childhood autonomic epilepsy
          frequently imitating encephalitis, syncope, migraine, sleep disorder,
          or gastroenteritis.
        supports: SUPPORT
        evidence_source: HUMAN_CLINICAL
        snippet: >-
          Panayiotopoulos syndrome probably affects 13% of children aged 3 to 6
          years who have had 1 or more afebrile seizures and 6% of such children
          in the 1- to 15-year age group.
        explanation: >-
          Gives both share figures and their denominators, which is why this
          record is expressed as a class rather than a normalized rate.
progression:
  - phase: Onset in early to mid childhood
    age_range: Early and mid childhood
    notes: >-
      Onset is in early to mid childhood, with the occipital EEG focus
      predominating in the youngest children. Two thirds of seizures occur during
      sleep, which is part of why episodes are witnessed as a child waking
      vomiting and pale.
    evidence:
      - reference: PMID:16950946
        reference_title: >-
          Panayiotopoulos syndrome: a benign childhood autonomic epilepsy
          frequently imitating encephalitis, syncope, migraine, sleep disorder,
          or gastroenteritis.
        supports: SUPPORT
        evidence_source: HUMAN_CLINICAL
        snippet: >-
          Two thirds of seizures occur during sleep.
        explanation: >-
          Documents the sleep predominance that characterizes the presentation in
          this phase.
  - phase: Remission within a few years
    age_range: Later childhood to adolescence
    notes: >-
      Seizures are infrequent and remit within a few years of onset. The EEG foci
      migrate through occipital, frontopolar, and centro-parieto-temporal
      distributions before disappearing by adolescence, and adult epilepsy risk
      returns to population baseline.
    evidence:
      - reference: PMID:16950946
        reference_title: >-
          Panayiotopoulos syndrome: a benign childhood autonomic epilepsy
          frequently imitating encephalitis, syncope, migraine, sleep disorder,
          or gastroenteritis.
        supports: SUPPORT
        evidence_source: HUMAN_CLINICAL
        snippet: >-
          Panayiotopoulos syndrome is remarkably benign in terms of seizure
          frequency and evolution.
        explanation: >-
          States the benign evolution that defines this phase.
diagnosis:
  - name: Electroencephalography
    description: >-
      EEG is the only investigation that returns an abnormal result, and it is
      therefore the diagnostic test. It typically shows multiple spikes in
      various locations, with a distribution that depends on the child's age.
      Imaging is normal.
    diagnosis_term:
      preferred_term: Electroencephalography
      term:
        id: NCIT:C38054
        label: Electroencephalography
    results: >-
      Shifting or multiple spike foci, occipital-predominant in younger children
      and migrating to frontopolar and centro-parieto-temporal distributions with
      age.
    evidence:
      - reference: PMID:16950946
        reference_title: >-
          Panayiotopoulos syndrome: a benign childhood autonomic epilepsy
          frequently imitating encephalitis, syncope, migraine, sleep disorder,
          or gastroenteritis.
        supports: SUPPORT
        evidence_source: HUMAN_CLINICAL
        snippet: >-
          An electroencephalogram is the only investigation with abnormal
          results, usually showing multiple spikes in various brain locations.
        explanation: >-
          Establishes EEG as the sole informative investigation and describes the
          expected finding.
treatments:
  - name: Education and Conservative Management
    description: >-
      Because seizures are infrequent and the syndrome remits, the primary
      intervention is not a drug. Educating the family about what an autonomic
      seizure looks like, and about the fact that a prolonged episode leaves no
      deficit, is the stated cornerstone of management and is what prevents the
      cycle of emergency presentation, misdiagnosis, and unnecessary
      investigation that this syndrome otherwise generates.
    therapeutic_modality: BEHAVIORAL
    treatment_term:
      preferred_term: Supportive Care
      term:
        id: NCIT:C15747
        label: Supportive Care
    evidence:
      - reference: PMID:16950946
        reference_title: >-
          Panayiotopoulos syndrome: a benign childhood autonomic epilepsy
          frequently imitating encephalitis, syncope, migraine, sleep disorder,
          or gastroenteritis.
        supports: SUPPORT
        evidence_source: OTHER
        snippet: >-
          Education about Panayiotopoulos syndrome is the cornerstone of
          management.
        explanation: >-
          States that education is the cornerstone of management for this
          syndrome, which is why it is curated as the primary intervention.
      - reference: PMID:16950946
        reference_title: >-
          Panayiotopoulos syndrome: a benign childhood autonomic epilepsy
          frequently imitating encephalitis, syncope, migraine, sleep disorder,
          or gastroenteritis.
        supports: SUPPORT
        evidence_source: HUMAN_CLINICAL
        snippet: >-
          The consequence is avoidable misdiagnosis, high morbidity, and costly
          mismanagement.
        explanation: >-
          Records the cost of failing to recognize the syndrome, which is the
          harm that education is intended to prevent.
      - reference: PMID:16950946
        reference_title: >-
          Panayiotopoulos syndrome: a benign childhood autonomic epilepsy
          frequently imitating encephalitis, syncope, migraine, sleep disorder,
          or gastroenteritis.
        supports: SUPPORT
        evidence_source: OTHER
        snippet: >-
          Prophylactic treatment with antiepileptic medication may not be needed
          for most patients.
        explanation: >-
          The management recommendation that follows from the benign course and
          low seizure frequency, and the reason no antiseizure medication is
          curated as a primary treatment in this entry.
  - name: Benzodiazepine Rescue for Autonomic Status Epilepticus
    description: >-
      What to do acutely, as the counterpart to the avoidance entry below.
      Seizures in this syndrome are unusually benzodiazepine-responsive: in an
      emergency-department comparison, every patient with the syndrome was
      controlled by a small dose of midazolam at 0.1 mg/kg, whereas every patient
      with acute encephalopathy required at least three times that. So the same
      observation is simultaneously the treatment and a diagnostic discriminator,
      and a child who needs escalating doses should prompt reconsideration of the
      diagnosis rather than more drug.

      This does not contradict the conservative posture of this entry. Most
      seizures need no acute treatment at all and prophylaxis is usually
      unnecessary; the point is that when a prolonged episode does warrant
      intervention, a small benzodiazepine dose is what is indicated, and
      escalation beyond it is where the iatrogenic risk recorded below begins.
    therapeutic_modality: SMALL_MOLECULE
    treatment_term:
      preferred_term: Pharmacotherapy
      term:
        id: NCIT:C15986
        label: Pharmacotherapy
      therapeutic_agent:
        - preferred_term: midazolam
          term:
            id: CHEBI:6931
            label: midazolam
    target_mechanisms:
      - target: Autonomic Status Epilepticus
        treatment_effect: INHIBITS
        description: >-
          Terminates the prolonged seizure. It acts on seizure expression, not on
          the maturational susceptibility upstream, which is why it is a rescue
          measure rather than a disease-modifying one.
    evidence:
      - reference: PMID:35153087
        reference_title: >-
          Differentiating early clinical features of Panayiotopoulos syndrome
          from acute encephalopathy.
        supports: SUPPORT
        evidence_source: HUMAN_CLINICAL
        snippet: >-
          In addition, seizures were treatable in all patients with PS with a
          small dose of midazolam (0.1 mg/kg), but all patients with acute
          encephalopathy required midazolam at 0.3 mg/kg or more (P < 0.001).
        explanation: >-
          The one quantitatively supported acute-treatment finding for this
          syndrome, and simultaneously a diagnostic discriminator: complete
          response at 0.1 mg/kg in every case, against a threefold-or-greater
          requirement in the condition it is mistaken for.
  - name: Avoidance of Aggressive Acute Treatment
    description: >-
      A treatment entry recording what not to do. Autonomic status epilepticus
      here is alarming and prolonged, and it invites escalation, but the source
      is explicit that aggressive treatment may itself cause iatrogenic
      complications including cardiorespiratory arrest. This is a distinct hazard
      from the seizure-intrinsic cardiorespiratory risk recorded in the
      self-limited-label discussion: here the harm comes from the response rather
      than from the event. Because the prolonged episode leaves no residual
      deficit, the risk-benefit calculation favours thorough evaluation over
      aggressive intervention.
    therapeutic_modality: BEHAVIORAL
    treatment_term:
      preferred_term: Supportive Care
      term:
        id: NCIT:C15747
        label: Supportive Care
    evidence:
      - reference: PMID:16950946
        reference_title: >-
          Panayiotopoulos syndrome: a benign childhood autonomic epilepsy
          frequently imitating encephalitis, syncope, migraine, sleep disorder,
          or gastroenteritis.
        supports: SUPPORT
        evidence_source: OTHER
        snippet: >-
          Autonomic status epilepticus in the acute stage needs thorough
          evaluation; aggressive treatment may cause iatrogenic complications
          including cardiorespiratory arrest.
        explanation: >-
          States both halves of the recommendation: the acute episode warrants
          thorough evaluation, and aggressive treatment carries its own risk of
          cardiorespiratory arrest.
      - reference: PMID:16950946
        reference_title: >-
          Panayiotopoulos syndrome: a benign childhood autonomic epilepsy
          frequently imitating encephalitis, syncope, migraine, sleep disorder,
          or gastroenteritis.
        supports: SUPPORT
        evidence_source: HUMAN_CLINICAL
        snippet: >-
          Autonomic status epilepticus imparts no residual neurologic deficit.
        explanation: >-
          The outcome fact that makes conservative management defensible: there
          is no deficit to prevent by escalating.
differential_diagnoses:
  - name: Acute Encephalopathy or Encephalitis
    description: >-
      The most consequential differential and the reason these children reach an
      emergency department. Prolonged unresponsiveness with vomiting in a young
      child reads as encephalitis. A comparison of emergency presentations found
      the discriminator is convulsion duration: 90 percent of acute
      encephalopathy patients had convulsive seizures of at least 15 minutes,
      against 17 percent of this syndrome.
    distinguishing_features:
      - Convulsive seizures of at least 15 minutes are typical of acute encephalopathy and unusual here.
      - Seizures here are controlled by midazolam at 0.1 mg/kg; acute encephalopathy needs at least threefold more.
      - No residual neurological deficit follows the prolonged episode.
    evidence:
      - reference: PMID:35153087
        reference_title: >-
          Differentiating early clinical features of Panayiotopoulos syndrome
          from acute encephalopathy.
        supports: SUPPORT
        evidence_source: HUMAN_CLINICAL
        snippet: >-
          Most patients (90%) with acute encephalopathy had convulsive seizures
          of greater than or equal to 15 min, whereas only three patients (17%)
          with PS had convulsive seizures of greater than or equal to 15 min
        explanation: >-
          Provides a quantified bedside discriminator between the two conditions
          in the setting where the distinction actually has to be made.
      - reference: PMID:35153087
        reference_title: >-
          Differentiating early clinical features of Panayiotopoulos syndrome
          from acute encephalopathy.
        supports: SUPPORT
        evidence_source: HUMAN_CLINICAL
        snippet: >-
          In addition, seizures were treatable in all patients with PS with a
          small dose of midazolam (0.1 mg/kg), but all patients with acute
          encephalopathy required midazolam at 0.3 mg/kg or more (P < 0.001).
        explanation: >-
          Backs the treatability bullet in distinguishing_features, which
          previously stood unsupported in this block. Drug responsiveness is a
          second discriminator independent of convulsion duration, and a useful
          one because it declares itself within minutes of the first dose rather
          than requiring the episode to run its course.
  - name: Cyclic Vomiting Syndrome
    description: >-
      Separated from the other non-epileptic mimics because it is the hardest of
      them to exclude clinically. Both conditions produce recurrent, stereotyped,
      prolonged vomiting episodes in a child who is well between attacks, and
      both can involve pallor and lethargy. The distinction rests on the
      accompanying features and on the EEG rather than on the vomiting itself.
    distinguishing_features:
      - Pupillary change, eye deviation, and impaired awareness accompany the vomiting in the epilepsy.
      - Interictal EEG shows multifocal spikes, whereas it is normal in cyclic vomiting syndrome.
      - Two thirds of episodes arise from sleep in the epilepsy.
      - Episodes can end in hemiconvulsions or generalized convulsions in the epilepsy.
    evidence:
      - reference: PMID:16950946
        reference_title: >-
          Panayiotopoulos syndrome: a benign childhood autonomic epilepsy
          frequently imitating encephalitis, syncope, migraine, sleep disorder,
          or gastroenteritis.
        supports: SUPPORT
        evidence_source: HUMAN_CLINICAL
        snippet: >-
          The clinical features of Panayiotopoulos syndrome are frequently
          mistaken as nonepileptic conditions such as acute encephalitis,
          syncope, migraine, cyclic vomiting syndrome, motion sickness, sleep
          disorder, or gastroenteritis.
        explanation: >-
          Names cyclic vomiting syndrome specifically among the conditions this
          syndrome is mistaken for.
  - name: Gastroenteritis, Migraine, Syncope, and Motion Sickness
    description: >-
      The remaining non-epileptic mimics. Grouped because they share the feature
      that matters here: none is epilepsy, and each sends the child down a
      different and unnecessary diagnostic path. Cyclic vomiting syndrome is
      listed separately above because it is materially harder to exclude.
    distinguishing_features:
      - Stereotyped episodes with a consistent autonomic sequence rather than variable illness.
      - Accompanying pallor, pupillary change, and eye deviation.
      - Abnormal interictal EEG with multifocal spikes.
    evidence:
      - reference: PMID:16950946
        reference_title: >-
          Panayiotopoulos syndrome: a benign childhood autonomic epilepsy
          frequently imitating encephalitis, syncope, migraine, sleep disorder,
          or gastroenteritis.
        supports: SUPPORT
        evidence_source: HUMAN_CLINICAL
        snippet: >-
          The clinical features of Panayiotopoulos syndrome are frequently
          mistaken as nonepileptic conditions such as acute encephalitis,
          syncope, migraine, cyclic vomiting syndrome, motion sickness, sleep
          disorder, or gastroenteritis.
        explanation: >-
          Enumerates the non-epileptic conditions this syndrome imitates, which
          is the content of this grouped differential.
  - name: Self-Limited Epilepsy with Centrotemporal Spikes
    description: >-
      The sibling syndrome, and on the leading account the late-onset phenotype
      of the same maturational susceptibility. Distinguished by later onset and
      by orofacial and speech-arrest semiology rather than autonomic symptoms.
      The two can occur in the same patient. dismech carries a separate entry.
    distinguishing_features:
      - Later onset in mid to late childhood.
      - Orofacial sensorimotor seizures with speech arrest and hypersalivation rather than emesis.
      - Centrotemporal spikes rather than shifting occipital-predominant foci.
    evidence:
      - reference: PMID:16950946
        reference_title: >-
          Panayiotopoulos syndrome: a benign childhood autonomic epilepsy
          frequently imitating encephalitis, syncope, migraine, sleep disorder,
          or gastroenteritis.
        supports: SUPPORT
        evidence_source: OTHER
        snippet: >-
          Panayiotopoulos syndrome is probably the early-onset and Rolandic
          epilepsy the late-onset phenotype of a maturation-related benign
          childhood seizure-susceptibility syndrome.
        explanation: >-
          Supports the proposed relationship between the two syndromes. Marked
          PARTIAL because the source hedges the unification and the statement is
          a proposal rather than a demonstrated identity.
discussions:
  - discussion_id: seleas_why_autonomic_and_location_independent
    kind: KNOWLEDGE_GAP
    status: OPEN
    prompt: >-
      The published account holds that ictal discharges in this syndrome produce
      emesis and autonomic disturbance irrespective of where they begin. What
      circuit property of the young brain makes autonomic networks recruitable
      from anywhere, and why does that property disappear with age?
    attaches_to:
      - pathophysiology#Age-Specific Vulnerability of Central Autonomic Networks
      - pathophysiology#Multifocal Cortical Epileptogenicity with Age-Shifting Foci
    rationale: >-
      This is the central unexplained fact of the syndrome, and it is unusual
      enough to be worth stating plainly. In almost every other focal epilepsy,
      semiology localizes: an auditory aura implies auditory cortex, an epigastric
      rising sensation implies mesial temporal onset. Here the relationship is
      broken in both directions. The EEG foci are multifocal and migrate through
      occipital, frontopolar, and centro-parieto-temporal locations across
      childhood, yet the seizures remain stereotypically emetic throughout. The
      published resolution is to place the specificity not in the cortical
      generator but in the target: children's central autonomic networks are held
      to be particularly vulnerable to recruitment, so wherever the discharge
      starts, the autonomic system is what expresses it. If that is right it is a
      genuinely different architecture from the usual localizationist picture,
      and it should be testable. Two things make it more than a restatement of
      the observation. First, the same seizure sequence does not occur in adults,
      so whatever the property is, it is developmental and it closes. Second, the
      syndrome remits on roughly the same timescale over which the property is
      said to disappear, which raises the possibility that the maturation of
      autonomic network resilience is not merely permissive but is the thing that
      ends the epilepsy. No cellular or circuit-level account of the
      susceptibility exists in the cited literature.
    proposed_experiments:
      - experiment_id: exp_seleas_onset_zone_versus_semiology
        name: Test whether seizure semiology varies with EEG onset location
        description: >-
          Within a cohort of children with this syndrome, relate ictal onset
          location on video-EEG to the autonomic semiology of the corresponding
          seizure, testing directly whether emetic manifestations are independent
          of onset zone as the location-independence claim requires.
        decision_criterion: >-
          Equivalent emetic semiology across different onset zones would confirm
          location independence and support placing the specificity in the
          autonomic target; systematic variation with onset location would mean
          the syndrome is localizationist after all and the current account needs
          revision.
      - experiment_id: exp_autonomic_network_maturation_timecourse
        name: Developmental time-course of central autonomic network recruitability
        description: >-
          Characterize the maturation of central autonomic network connectivity
          across the relevant age range in typically developing children and in
          affected children, and test whether the timing of remission tracks a
          measurable change in that network rather than a change in cortical
          excitability.
        decision_criterion: >-
          Remission coinciding with autonomic-network maturation rather than with
          loss of cortical spikes would establish the autonomic target as the
          rate-limiting element and would reframe the syndrome as a disorder of
          autonomic recruitability rather than of cortical excitability.
    evidence:
      - reference: PMID:16950946
        reference_title: >-
          Panayiotopoulos syndrome: a benign childhood autonomic epilepsy
          frequently imitating encephalitis, syncope, migraine, sleep disorder,
          or gastroenteritis.
        supports: SUPPORT
        evidence_source: OTHER
        snippet: >-
          Ictal epileptic discharges in Panayiotopoulos syndrome, irrespective of
          their location at onset, activate autonomic disturbances and emesis, to
          which children are particularly vulnerable.
        explanation: >-
          The location-independence claim that this gap is about, stated
          explicitly in the authoritative clinical review.
      - reference: PMID:16950946
        reference_title: >-
          Panayiotopoulos syndrome: a benign childhood autonomic epilepsy
          frequently imitating encephalitis, syncope, migraine, sleep disorder,
          or gastroenteritis.
        supports: SUPPORT
        evidence_source: HUMAN_CLINICAL
        snippet: >-
          The symptoms/sequence of autonomic seizures and autonomic status
          epilepticus in Panayiotopoulos syndrome are specific to childhood, and
          they do not occur in adults.
        explanation: >-
          Establishes that the susceptibility is developmental and closes with
          age, which is the second half of the puzzle.
      - reference: PMID:37660659
        reference_title: >-
          A reappraisal of interictal EEG characteristics in self-limited
          epilepsy with autonomic seizures, formerly known as Panayiotopoulos
          syndrome or early-onset benign occipital epilepsy.
        supports: SUPPORT
        evidence_source: OTHER
        snippet: >-
          The interictal EEG characteristics of SeLEAS are multifocal EEG foci
          with age-dependent predominant locations; occipital (O) at 2-5 years
          old, and occipital and frontopolar (synchronous and independent O and
          Fp spikes) at 4-7 years old and centro-parieto-temporal (CPT) at 6-10
          years old.
        explanation: >-
          Documents that the cortical generator moves while the semiology does
          not, which is what makes the location-independence claim necessary in
          the first place.
  - discussion_id: seleas_occipital_versus_multifocal_definition
    kind: CONTROVERSY
    status: UNDER_DISCUSSION
    prompt: >-
      Is this syndrome electrographically defined by occipital spikes or by
      multifocal spikes, and is the evidence base strong enough to support any
      EEG criterion being definitional?
    attaches_to:
      - pathophysiology#Multifocal Cortical Epileptogenicity with Age-Shifting Foci
    rationale: >-
      The syndrome's naming history is a record of this argument. It was once
      called early-onset benign childhood occipital epilepsy, a name asserting
      that the occipital lobe was where the disease lived. The ILAE 2022
      reclassification abandoned that and named the syndrome for its autonomic
      semiology instead, and the current definition characterizes the EEG as
      multifocal. Both descriptions are partly right, which is the problem: the
      foci genuinely are occipital-predominant in the youngest children, and
      genuinely are multifocal and migrating across the whole age range, so a
      cross-sectional study will report whichever depending on the ages it
      sampled. A 2023 reappraisal of the EEG literature found that although
      enough cases have been studied, almost none of the studies analysed
      cross-sectional and longitudinal change systematically, and proposed an
      explicitly age-stratified EEG definition on that limited basis. The stake
      is practical: if occipital predominance is expected only at 2 to 5 years,
      then applying it as a diagnostic criterion in a 9-year-old will produce
      false negatives, and conversely a multifocal criterion may be too loose to
      exclude other childhood epilepsies.
    proposed_experiments:
      - experiment_id: exp_seleas_longitudinal_eeg_cohort
        name: Longitudinal EEG cohort with serial recordings through remission
        description: >-
          A prospective cohort with serial EEG from diagnosis through remission,
          analysed longitudinally rather than cross-sectionally, to establish
          whether the proposed age-stratified focus distribution is reproducible
          within individual children.
        decision_criterion: >-
          Reproducible within-child migration through the proposed sequence would
          justify an age-stratified EEG criterion; heterogeneous trajectories
          would mean no single EEG criterion should be definitional.
      - experiment_id: exp_seleas_eeg_criterion_discrimination
        name: Discriminative performance of candidate EEG criteria
        description: >-
          Test occipital-predominant versus multifocal EEG criteria for
          sensitivity and specificity against other childhood focal epilepsies,
          stratified by age at recording.
        decision_criterion: >-
          A criterion achieving useful specificity against the sibling
          centrotemporal syndrome and other childhood epilepsies could be adopted
          as definitional; poor discrimination would confirm that the syndrome
          should remain semiologically rather than electrographically defined.
    evidence:
      - reference: PMID:37660659
        reference_title: >-
          A reappraisal of interictal EEG characteristics in self-limited
          epilepsy with autonomic seizures, formerly known as Panayiotopoulos
          syndrome or early-onset benign occipital epilepsy.
        supports: SUPPORT
        evidence_source: OTHER
        snippet: >-
          Although previous studies investigated the details of interictal EEG
          characteristics in a sufficient number of SeLEAS cases, there were few
          systematically analyzing cross sectional and longitudinal EEG changes
          except one study.
        explanation: >-
          States the evidential weakness underlying any EEG criterion for this
          syndrome, which is the core of the controversy.
      - reference: PMID:37660659
        reference_title: >-
          A reappraisal of interictal EEG characteristics in self-limited
          epilepsy with autonomic seizures, formerly known as Panayiotopoulos
          syndrome or early-onset benign occipital epilepsy.
        supports: SUPPORT
        evidence_source: OTHER
        snippet: >-
          Despite these limited evidence, I propose the following practical and
          useful EEG definition.
        explanation: >-
          The author explicitly acknowledges proposing a definition on limited
          evidence, which is why this is recorded as an open controversy rather
          than as settled criteria.
      - reference: PMID:35503717
        reference_title: >-
          International League Against Epilepsy classification and definition of
          epilepsy syndromes with onset in childhood: Position paper by the ILAE
          Task Force on Nosology and Definitions.
        supports: SUPPORT
        evidence_source: OTHER
        snippet: >-
          Based on the 2017 Classification of Seizures and Epilepsies, some
          syndrome names have been updated using terms directly describing the
          seizure semiology.
        explanation: >-
          Documents the ILAE's shift to semiology-based naming, which is what
          moved this syndrome away from its occipital label.
  - discussion_id: seleas_cognitive_comorbidity_contested
    kind: CONTROVERSY
    status: OPEN
    prompt: >-
      Is cognition genuinely normal in this syndrome, as the syndrome definition
      asserts, or is there a mild diffuse comorbidity that group-level normality
      conceals?
    attaches_to:
      - pathophysiology#Multifocal Cortical Epileptogenicity with Age-Shifting Foci
      - pathophysiology#Age-Dependent Remission
    rationale: >-
      Stated as a contradiction this looks unresolvable, but the two principal
      studies actually agree on the data and differ on what to call it, which is
      a more tractable disagreement.

      A consecutive series of 93 patients found IQ and Wechsler subtests within
      normal limits, while also finding statistically significant differences
      against controls on arithmetic, comprehension, and picture arrangement. A
      smaller retrospective series of 18 found mean full-scale IQ of 93.5,
      explicitly within the normal range yet significantly below the normative
      mean, with reaction times, visual attention, visual-motor integration, and
      verbal memory all significantly lower, an average lag of 8 months in
      arithmetic speed and 11 months in reading speed, and elevated internalizing
      behavioural problems. Both studies therefore report normal-range
      performance alongside reproducible sub-normative differences. The larger
      study reads that as normality with minor variation; the smaller reads the
      same shape as diffuse cognitive dysfunction and comorbidity.

      Three things make this worth resolving rather than splitting the
      difference. First, the syndrome definition asserts normal development, and
      a definitional claim that the data only support at group level will
      systematically miss the affected minority; more than half of the children
      in the smaller series had mild-to-severe academic underachievement, which
      a normal mean IQ conceals entirely. Second, the deficits reported are
      exactly the domains that an interictal multifocal spike burden would be
      expected to touch, so the question connects to the pathograph rather than
      being purely clinical. Third, the smaller series is 18 children assessed at
      a mean age of 4 years 7 months, near the peak of the electrographic
      abnormality, whereas the syndrome's premise is that everything resolves by
      adolescence, so the two studies may be sampling different points on a
      trajectory rather than disagreeing about a fixed state. Neither followed
      cognition longitudinally through remission, which is the study that would
      settle it.
    proposed_experiments:
      - experiment_id: exp_seleas_longitudinal_cognition_through_remission
        name: Longitudinal neuropsychology from diagnosis through remission
        description: >-
          Serial neuropsychological and academic assessment of the same children
          from diagnosis through EEG normalization and seizure remission, with
          matched controls, testing whether the sub-normative differences track
          the spike burden and resolve with it or persist after remission.
        decision_criterion: >-
          Deficits that resolve as the foci disappear would support a transient
          comorbidity of the active phase and vindicate the self-limited framing;
          deficits persisting beyond remission would mean the syndrome leaves a
          cognitive trace and the definition's claim of normal development needs
          qualifying.
      - experiment_id: exp_seleas_spike_burden_versus_cognition
        name: Interictal spike burden against domain-specific performance
        description: >-
          Relate quantified interictal spike burden and focus location on
          extended EEG to performance in the specific domains reported as
          affected, namely visual attention, visual-motor integration, verbal
          memory, and arithmetic and reading speed.
        decision_criterion: >-
          A dose relationship between spike burden and domain performance would
          make the comorbidity mechanistically attributable to the epilepsy
          rather than incidental, and would identify the children worth
          monitoring.
    evidence:
      - reference: PMID:20528983
        reference_title: >-
          Panayiotopoulos syndrome: a clinical, EEG, and neuropsychological study
          of 93 consecutive patients.
        supports: SUPPORT
        evidence_source: HUMAN_CLINICAL
        snippet: >-
          On neuropsychological testing, IQ and subtests of Wechsler Intelligence
          Scale for Children-Revised (WISC-R) were within normal limits, although
          some minor statistically significant differences were found in
          arithmetic, comprehension, and picture arrangement in comparison with
          controls.
        explanation: >-
          The larger series, and the normality side of the disagreement. Note it
          contains both halves: normal limits overall, yet reproducible
          differences against controls in specific domains.
      - reference: PMID:32608507
        reference_title: Neurocognitive and behavioural profile in Panayiotopoulos syndrome.
        supports: SUPPORT
        evidence_source: HUMAN_CLINICAL
        snippet: >-
          Mean full-scale IQ (93.5; range 76-123; p=0.04) and performance IQ
          (93.2; range 76-126; p=0.04) were within the normal range, although
          significantly lower compared to the normative mean.
        explanation: >-
          The comorbidity side, and the sentence that shows the disagreement is
          interpretive rather than empirical: the same pattern of normal-range
          but sub-normative performance is reported, and read differently.
      - reference: PMID:32608507
        reference_title: Neurocognitive and behavioural profile in Panayiotopoulos syndrome.
        supports: SUPPORT
        evidence_source: HUMAN_CLINICAL
        snippet: >-
          On average, patients with Panayiotopoulos syndrome were 8 months behind
          in arithmetic speed and 11 months behind in reading speed for the
          number of months in school.
        explanation: >-
          The concrete academic consequence, which is what makes the distinction
          matter beyond psychometrics. A group mean IQ in the normal range does
          not tell a family whether their child is losing school months.
      - reference: PMID:32608507
        reference_title: Neurocognitive and behavioural profile in Panayiotopoulos syndrome.
        supports: SUPPORT
        evidence_source: HUMAN_CLINICAL
        snippet: >-
          Mild-to-severe academic underachievement was present in more than half
          of the children with Panayiotopoulos syndrome.
        explanation: >-
          The proportion affected, which a normal group mean conceals entirely.
          Marked PARTIAL because it comes from 18 retrospectively analysed
          children at a single centre, so it establishes that the minority is not
          small rather than measuring how large it is.
  - discussion_id: seleas_is_self_limited_label_safe
    kind: CONTROVERSY
    status: OPEN
    prompt: >-
      The syndrome is named self-limited and described as remarkably benign, yet
      it can evolve into encephalopathy with status epilepticus in sleep and
      measurable cognitive decline, and rare cardiorespiratory arrest is
      acknowledged. Does the benign label adequately convey the residual risk?
    attaches_to:
      - pathophysiology#Age-Dependent Remission
      - pathophysiology#Autonomic Status Epilepticus
    rationale: >-
      The benign framing is well earned for the typical patient: seizures are
      few, prolonged episodes leave no deficit, and adult epilepsy risk returns
      to baseline. That framing also does real clinical work, since it is what
      justifies not treating and what breaks the misdiagnosis cycle. But two
      things sit uneasily with it. First, an atypical evolution exists in which
      occipital foci progress to synchronous frontopolar and occipital spikes and
      then to continuous spike-wave in sleep, with neuropsychological ability
      including IQ deteriorating during that period. In the reported cases the
      children ultimately recovered and came off medication, so even the atypical
      course was ultimately self-limited, but the cognitive decline was real while
      it lasted. Second, the same review that calls the syndrome remarkably
      benign also notes that autonomic seizures are potentially life-threatening
      in the rare context of cardiorespiratory arrest and states that this needs
      further study. The tension is not that the label is wrong but that it is a
      statement about the central tendency being applied to an individual patient,
      and the features that would identify the minority at risk, the reported
      candidate being the frontopolar-occipital focus combination, are not
      validated as predictors. The curation question is whether this entry should
      model the atypical evolution as a distinct trajectory rather than as an
      exception to a benign course.
    proposed_experiments:
      - experiment_id: exp_seleas_predictors_of_atypical_evolution
        name: Prospective identification of predictors of atypical evolution
        description: >-
          A prospective cohort with serial EEG and neuropsychological assessment,
          testing whether the frontopolar-occipital focus combination, seizure
          burden, or age at onset predicts progression to continuous spike-wave
          in sleep and cognitive decline.
        decision_criterion: >-
          A validated predictor would justify stratified surveillance and would
          support modelling the atypical evolution as a separate trajectory;
          absence of any predictor would support retaining the benign framing with
          routine monitoring for all.
      - experiment_id: exp_seleas_cardiorespiratory_risk_quantification
        name: Quantification of cardiorespiratory risk during autonomic seizures
        description: >-
          Systematic cardiorespiratory monitoring during autonomic seizures and
          autonomic status epilepticus in this syndrome, to establish whether the
          acknowledged rare risk of cardiorespiratory arrest is quantifiable and
          whether any seizure feature precedes it.
        decision_criterion: >-
          A measurable and predictable risk would change management advice for
          prolonged episodes; confirmation that events are vanishingly rare and
          unpredictable would support the current conservative approach.
    evidence:
      - reference: PMID:32020894
        reference_title: >-
          Encephalopathy related to status epilepticus during slow sleep (ESES)
          as atypical evolution of Panayiotopoulos syndrome: an EEG and
          neuropsychological study.
        supports: SUPPORT
        evidence_source: HUMAN_CLINICAL
        snippet: >-
          Neuropsychological ability, including IQ, deteriorated during the CSWS
          period in both patients.
        explanation: >-
          Documents measurable cognitive decline during the atypical evolution,
          which is the observation that sits most awkwardly with an unqualified
          benign label.
      - reference: PMID:32020894
        reference_title: >-
          Encephalopathy related to status epilepticus during slow sleep (ESES)
          as atypical evolution of Panayiotopoulos syndrome: an EEG and
          neuropsychological study.
        supports: SUPPORT
        evidence_source: HUMAN_CLINICAL
        snippet: >-
          PS can progress to ESES if the clinical course exhibits atypical
          evolution. The initial autonomic symptom of the seizures and interictal
          Fp-O EEG foci should be carefully monitored in patients with CSWS or
          ESES.
        explanation: >-
          States both the atypical evolution and the candidate warning feature,
          the frontopolar-occipital focus combination, that a stratified approach
          would need to validate.
      - reference: PMID:32020894
        reference_title: >-
          Encephalopathy related to status epilepticus during slow sleep (ESES)
          as atypical evolution of Panayiotopoulos syndrome: an EEG and
          neuropsychological study.
        supports: SUPPORT
        evidence_source: HUMAN_CLINICAL
        snippet: >-
          However, the seizures and EEG findings gradually resolved, and AEDs
          were successfully terminated in both patients.
        explanation: >-
          The counterweight: even the atypical course ultimately remitted, which
          is why this is recorded as a live tension rather than as a refutation of
          the self-limited label. PARTIAL because two cases cannot establish the
          general outcome of atypical evolution.
      - reference: PMID:16950946
        reference_title: >-
          Panayiotopoulos syndrome: a benign childhood autonomic epilepsy
          frequently imitating encephalitis, syncope, migraine, sleep disorder,
          or gastroenteritis.
        supports: SUPPORT
        evidence_source: HUMAN_CLINICAL
        snippet: >-
          However, autonomic seizures are potentially life-threatening in the
          rare context of cardiorespiratory arrest, an area in which additional
          study is required.
        explanation: >-
          The benign-framing source's own acknowledged exception, including its
          statement that the area needs further study.
📚

References & Deep Research

References

2
PMID:16950946
Panayiotopoulos syndrome: a benign childhood autonomic epilepsy frequently imitating encephalitis, syncope, migraine, sleep disorder, or gastroenteritis.
No top-level findings curated for this source.
PMID:35503717
International League Against Epilepsy classification and definition of epilepsy syndromes with onset in childhood: Position paper by the ILAE Task Force on Nosology and Definitions.
No top-level findings curated for this source.

Deep Research

1
Claude Code ▸
1. Disease Information
claude-haiku-4-5-20251001, claude-opus-5[1m] 28 citations 2026-08-05T01:31:49.128317

1. Disease Information

Overview

Self-limited epilepsy with autonomic seizures (SeLEAS) is a childhood-onset focal epilepsy syndrome in which the seizures are dominated by autonomic manifestations — above all vomiting — rather than by motor or sensory features. It affects otherwise normal children, typically between ages 3 and 6, produces very few seizures overall (often only one), and remits spontaneously within a couple of years. Its clinical signature is a strange one for epilepsy: a fully conscious child who starts retching, goes pale, and then over the next half hour drifts into unresponsiveness with the eyes deviated to one side, most often out of sleep.

The MONDO definition (retrieved from OLS4, 2026-08-05):

"A childhood-onset self-limited focal epilepsy syndrome characterized by the onset in early childhood of focal autonomic seizures that are often prolonged. The EEG commonly shows high amplitude focal spikes typically activated by sleep. Seizures are infrequent in most patients. Seizures are self-limiting with remission typically within a few years from onset."

The 2006 international consensus definition (Ferrie et al., PMID:16483404) is the one most cited in the clinical literature:

"We conclude that PS is a common idiopathic, benign seizure disorder of childhood, which should be classified as an autonomic epilepsy, rather than an occipital epilepsy."

Covanis (PMID:16950946) quotes the consensus wording directly:

"An expert consensus has defined Panayiotopoulos syndrome as 'a benign age-related focal seizure disorder occurring in early and mid-childhood. It is characterized by seizures, often prolonged, with predominantly autonomic symptoms, and by an EEG [electroencephalogram] that shows shifting and/or multiple foci, often with occipital predominance.'"

Key identifiers

Resource Identifier Notes
MONDO MONDO:0020307 Label: "Self-limited epilepsy with autonomic seizures". Verified live via OLS4 2026-08-05
Orphanet ORPHA:98815 MONDO xref
UMLS C0393676 MONDO xref
MedGen 581520 MONDO xref
SNOMED CT 230387008 MONDO xref
GARD 0019581 MONDO xref
ICD-9-CM 345.80 MONDO xref
ICD-10 G40.0 Conventional mapping (localization-related idiopathic epilepsy with seizures of localized onset). Not a curated MONDO xref — treat as low confidence
ICD-11 8A61.2Y (reported) Secondary sources only; low confidence, verify against the WHO browser before curating
OMIM none No OMIM xref exists in MONDO. Consistent with the absence of a Mendelian gene
MeSH no dedicated descriptor Indexed under Epilepsies, Partial / Epilepsy, Benign Neonatal headings

Synonyms and alternative names

From MONDO (OLS4) plus the literature:

  • Panayiotopoulos syndrome (the eponym; still overwhelmingly dominant in the literature)
  • SeLEAS (abbreviation)
  • Benign childhood occipital epilepsy, Panayiotopoulos type
  • Early-onset benign childhood occipital epilepsy (EBOE)
  • Early-onset benign occipital epilepsy
  • Benign childhood epilepsy with occipital paroxysms, early-onset variant
  • Benign childhood autonomic epilepsy
  • Idiopathic childhood occipital epilepsy of Panayiotopoulos

Deprecated terminology to avoid: "benign" and "idiopathic". Quito-Betancourt & Reyes Valenzuela (PMID:37714124) state: "Using the term 'benign' to refer to them is no longer recommended, as this would ignore the comorbidities some individuals suffer. Also, the term 'idiopathic' is now only used to refer to the syndromes classified as Idiopathic Generalized Epilepsies."

Source of information

Almost entirely aggregated disease-level and cohort-level clinical sources: hospital-based prospective and retrospective case series (Caraballo n=192, PMID:17442007; Specchio n=93, PMID:20528983; Değerliyurt n=38, PMID:24840752), an international expert consensus (PMID:16483404), and ILAE nosology documents. There are no EHR-derived phenotype studies, no disease registries, and no population biobank analyses specific to SeLEAS. The one population-based incidence study (PMID:29571057) used prospective clinician reporting within a defined UK/Welsh catchment area, not EHR extraction.

2. Etiology

Disease causal factors

Primary cause: unknown; presumed age-dependent maturational. The dominant framing across three decades of literature is that SeLEAS is not caused by a lesion or a single gene but by a transient, developmentally timed state of cortical hyperexcitability that preferentially engages autonomic circuitry. Panayiotopoulos himself (PMID:15145296) put it this way:

"Pathophysiology of Panayiotopoulos syndrome is unknown, but it is likely that they are due to diffuse maturation-related epileptogenicity activating susceptible-for-children emetic centers and the hypothalamus."

Covanis (PMID:16950946) frames it as one pole of a shared childhood susceptibility:

"Panayiotopoulos syndrome is probably the early-onset and Rolandic epilepsy the late-onset phenotype of a maturation-related benign childhood seizure-susceptibility syndrome."

Structural etiology is exclusionary. Per the ILAE 2022 diagnostic criteria table, "Structural cause for the epilepsy" on imaging is an exclusionary criterion. Note however that Panayiotopoulos (PMID:15145296) reported that among children with autonomic seizures and autonomic status epilepticus generally, "10-20% are due to cerebral pathology" — those cases are symptomatic focal epilepsy, not SeLEAS.

A boundary case worth curating: Cooper et al. (PMID:35871494) found that children with cerebral palsy from prenatal/perinatal vascular injury frequently develop an electroclinically identical picture, which they termed "self-limited focal epilepsy-variant" precisely because the current ILAE classification forbids the diagnosis in the presence of a brain lesion:

"Fifty-six (60%) children with seizures had electroclinical features of a self-limited focal epilepsy of childhood; we diagnosed these children with a self-limited focal epilepsy-variant given the current International League Against Epilepsy classification precludes a diagnosis of self-limited focal epilepsy in children with a brain lesion. … Self-limited focal epilepsy-variant usually manifested with a mix of autonomic and brachio-facial motor features, and occipital and/or centro-temporal spikes on EEG."

This is mechanistically informative: it suggests the autonomic-seizure phenotype reflects an age-dependent network state that a structural lesion can also unmask, rather than a lesion-free requirement of the mechanism itself.

Risk factors — genetic

  • No established causal gene. ILAE syndrome page (epilepsydiagnosis.org, CC BY-SA 4.0, text last updated 2024-06-30): "There are no established genes, outside of rare case reports, and no clear indication to perform genetic testing."
  • No classical inheritance pattern. ILAE: "There is a higher prevalence of febrile seizures in first degree relatives, suggesting genetic factors play a role, but there is no classical inheritance pattern."
  • SCN1A is the one gene with credible (rare) evidence. Kivity et al. (PMID:28192756) described a large GEFS+ family segregating a heterozygous pathogenic SCN1A missense variant in which four members had Panayiotopoulos syndrome: "A pathogenic heterozygous SCN1A (c.2624C>A; p.Thr875Lys) variant was identified. Sixteen of the 18 variant positive family members were affected (88% penetrance): 8 with febrile seizures, 2 febrile seizures plus, 1 unclassified seizures and 5 with self-limited focal epilepsy of childhood. Of these, one was diagnosed with atypical childhood epilepsy with centrotemporal spikes and four with Panayiotopoulos syndrome." Their conclusion: "the GEFS+ spectrum can extend to the self-limited focal epilepsies of childhood, including Panayiotopoulos syndrome."
  • Family history of febrile seizures and epilepsy is enriched. Değerliyurt et al. (PMID:24840752): "We found high rates of personal history of febrile convulsions, breath-holding spells, and family history of febrile convulsions, afebrile convulsion/epilepsy, migraine, and breath-holding spells."
  • Twin data argue against a simple genetic model. Taylor et al. (PMID:18669497), a twin and multiplex family study of benign occipital epilepsies of childhood: "Monozygotic twin pairs did not show a higher concordance rate than dizygotic twin pairs suggesting that BOEC may not be a purely genetic disorder. … Clinical genetic studies highlight the multifactorial aetiology of BOEC as monozygotic twins have low concordance suggesting that non-conventional genetic influences or environmental factors play a major role." This is the single most important genetic-etiology citation for the entry — it is a direct, human, evidence-based argument against over-genetic framing.
  • Complex/polygenic architecture is the working model for self-limited focal epilepsies generally. Tsai et al. (PMID:23294109), studying the related epilepsy-aphasia spectrum and BECTS families, found: "The frequencies of seizures in relatives of probands with EAS suggest that the underlying genetic influence of EAS is consistent with complex inheritance and similar to BECTS."

Risk factors — environmental

NOT AVAILABLE / largely negative. No toxin, infection, occupational, or dietary risk factor has been established. Specifically:

  • Antecedent and birth history are normal (ILAE syndrome page).
  • Sex: no risk difference. ILAE: "Both sexes are affected equally."
  • Age: the only robust "risk factor" is being in the 3–6 year window. This is the defining feature, not an incidental one.
  • Prior febrile seizures: present in 5–17% of patients (ILAE syndrome page) — plausibly a shared-susceptibility marker rather than a cause.
  • Sleep is a powerful precipitant (not a cause): two-thirds to >80% of seizures arise from sleep (see §3).

Protective factors

NOT AVAILABLE. No protective genetic variant, dietary factor, or lifestyle exposure has been reported for SeLEAS. The condition remits spontaneously regardless of treatment, which makes protective-factor studies both difficult and low-priority.

Gene–environment interactions

NOT AVAILABLE in any direct form. The strongest indirect statement is Taylor et al.'s twin-discordance finding (PMID:18669497) implying that "non-conventional genetic influences or environmental factors play a major role" — i.e. the field explicitly posits a G×E or epigenetic contribution but has not identified it.

3. Phenotypes

3.1 The cardinal phenotype — focal autonomic seizures

The single mandatory seizure type per ILAE 2022. Covanis (PMID:16950946) gives the canonical description:

"Autonomic epileptic seizures and autonomic status epilepticus are the cardinal manifestations of Panayiotopoulos syndrome. Autonomic seizures in Panayiotopoulos syndrome consist of episodes of disturbed autonomic function with emesis as the predominant symptom. Other autonomic manifestations include pallor (or, less often, flushing or cyanosis), mydriasis (or, less often, miosis), cardiorespiratory and thermoregulatory alterations, incontinence of urine and/or feces, hypersalivation, and modifications of intestinal motility."

Suggested HP terms (all verified against OLS4, 2026-08-05):

Phenotype HP term ID Notes
Focal autonomic seizure (parent) Focal autonomic seizure HP:0011154 The defining term
Aware autonomic seizure Focal aware autonomic seizure HP:0032740 Seizures typically begin with awareness preserved
Impaired-awareness autonomic seizure Focal impaired awareness autonomic seizure HP:0032755 Awareness is lost as the seizure evolves
Ictal emesis / GI phenomena Focal autonomic seizure with epigastric sensation/nausea/vomiting/other gastrointestinal phenomena HP:0011159 The most specific available term for the hallmark feature
Pallor/flushing Focal aware autonomic seizure with pallor/flushing HP:0032761
Cardiac autonomic features Focal autonomic seizure with palpitations/tachycardia/bradycardia/asystole HP:0032773
Autonomic dysfunction (generic parent) Abnormality of the autonomic nervous system HP:0002270 Use only if a more specific term does not fit

3.2 Phenotype table with frequencies

Phenotype Type HP term ID Frequency Source
Ictal vomiting / emesis Symptom (autonomic) Focal autonomic seizure with epigastric…vomiting… HP:0011159 ~74–83% of patients ("usually culminated in vomiting (77.4% of patients)") PMID:20528983
Vomiting (generic) Symptom Vomiting HP:0002013 — —
Nausea Symptom Nausea HP:0002018 Common, precedes emesis PMID:16950946
Pallor Clinical sign Pallor HP:0000980 Very frequent; "Emesis, pallor, or flushing was almost always among the first symptoms" PMID:20528983
Flushing Clinical sign — (use HP:0032761) HP:0032761 Less common than pallor PMID:16950946
Cyanosis Clinical sign Cyanosis HP:0000961 Less common PMID:31369969
Mydriasis Clinical sign Mydriasis HP:0011499 Frequent (miosis less often) PMID:16950946
Tonic eye deviation Clinical sign Abnormal conjugate eye movement HP:0000549 Very frequent; part of the original 1989 triad PMID:19469846, PMID:17442007
Impaired awareness / unresponsiveness Clinical sign Focal impaired awareness seizure HP:0002384 83.3% in one series PMID:17057874
Ictal syncope (flaccid unresponsiveness) Clinical sign Syncope HP:0001279 ~20% of seizures ("In approximately one fifth of the seizures the child becomes unresponsive and flaccid"); 29.2% of an atypical-presentation series; 37.5% in a comparative cohort PMID:16950946; PMID:35063695; PMID:24777033
Autonomic status epilepticus (≥30 min) Clinical sign Focal non-convulsive status epilepticus with impairment of consciousness HP:0032861 ~50–55% of seizures ("More than half (55%) of seizures were longer than 30 min"); autonomic status in ~1/3 of patients PMID:20528983; PMID:24840752; PMID:17442007
Status epilepticus (generic) Clinical sign Status epilepticus HP:0002133 — —
Focal to bilateral tonic-clonic / hemiconvulsions Clinical sign Bilateral tonic-clonic seizure with focal onset HP:0007334 ~50% ("Only half of the seizures end with brief hemiconvulsions or generalized convulsions") PMID:16950946
Hemiclonic seizure Clinical sign Focal hemiclonic seizure HP:0006813 Component of the above PMID:16950946
Sleep-related occurrence Course feature — — ~67–81.5% ("Two thirds of seizures occur during sleep"; 81.5% sleep-related in Turkish series; all but 5/192 in Argentine series) PMID:16950946; PMID:24840752; PMID:17442007
Hypersalivation Symptom Excessive salivation HP:0003781 Reported PMID:16950946
Urinary/fecal incontinence Clinical sign Urinary incontinence HP:0000020 9.7% as a presenting feature in an atypical series PMID:35063695
Thermoregulatory change (hyperthermia without infection) Clinical sign — (no good HP term) — 14.6% as first manifestation in atypical series PMID:35063695
Ictal/postictal headache Symptom Headache HP:0002315 9.7% as initial manifestation; major migraine-mimic driver PMID:35063695; PMID:42348808
Cough as initial feature Symptom — — 4.8% PMID:35063695
Oral automatisms (sucking, chewing) Clinical sign — — 4.8% PMID:35063695
Visual symptoms (hallucinations, amaurosis) Symptom — — ~5% (contrast with Gastaut syndrome, where they dominate) PMID:24840752
Rolandic (centrotemporal) features Clinical sign — — 26% PMID:24840752
Ictal cardiorespiratory arrest Clinical sign (rare, severe) Apnea (HP:0002104) + Bradycardia (HP:0001662) HP:0002104 / HP:0001662 Exceptional; 4.8% of an atypical-presentation series (2/44) — not of unselected cases PMID:35063695; PMID:21822089; PMID:29926008
Interictal multifocal spikes Lab/EEG Multifocal epileptiform discharges HP:0010841 79.5–84% PMID:20528983; PMID:24840752
Occipital spikes Lab/EEG EEG with occipital focal spikes HP:0012016 75% in one series PMID:17057874
Centrotemporal spikes Lab/EEG EEG with centrotemporal focal spike waves HP:0012557 25% also had rolandic spikes PMID:17057874
Fixation-off sensitivity Lab/EEG Fixation-off epileptiform discharges HP:0025644 Eye closure activates posterior discharges in some ILAE EEG page
Normal EEG Lab/EEG — — 5.4–16.6% PMID:20528983; PMID:17057874

3.3 Cognitive and behavioral phenotypes — the "benign" caveat

This is the section where the old "benign" label has been most substantially revised, and it deserves careful curation because the evidence is genuinely split.

Evidence for cognitive comorbidity. Fonseca Wald et al. (PMID:32608507, n=18, Netherlands):

"Mean full-scale IQ (93.5; range 76-123; p=0.04) and performance IQ (93.2; range 76-126; p=0.04) were within the normal range, although significantly lower compared to the normative mean. … Simple auditory/visual reaction times, visual attention, visual-motor integration, and verbal memory were significantly lower compared to normative values. On average, patients with Panayiotopoulos syndrome were 8 months behind in arithmetic speed and 11 months behind in reading speed for the number of months in school. Behavioural questionnaires revealed significantly higher scores on reported internalizing behavioural problems."

Akca Kalem et al. (PMID:31398558, n=20 PS vs 20 Gastaut vs 20 controls):

"With regard to intelligence, the patients with PS scored less in all scales compared to the healthy controls. … Verbal memory problems were eminent in both of the patient groups; whereas, visual memory was impaired only in the group with PS. … Cognitive dysfunction is a more prominent and widespread feature of the patients with PS; whereas, the patients with GS suffer only from milder and isolated cognitive problems."

Hodges et al. (PMID:26709104, n=3): "Neuropsychological findings suggest that the patients had notable impairments on visual memory tasks, especially in comparison with verbal memory. … Academically, the patients were weak in numerical operations and spelling."

Evidence against clinically meaningful comorbidity. Specchio et al. (PMID:20528983, n=93 — by far the largest neuropsychologically characterized cohort):

"On neuropsychological testing, IQ and subtests of Wechsler Intelligence Scale for Children-Revised (WISC-R) were within normal limits, although some minor statistically significant differences were found in arithmetic, comprehension, and picture arrangement in comparison with controls."

And the ILAE syndrome page still states flatly: "Development and cognition are normal."

Curation recommendation: model this as a mild, contested phenotype with an explicit KNOWLEDGE_GAP discussion. The disagreement is real and traceable to cohort size and referral bias (the small tertiary-center cohorts find deficits; the large consecutive-referral cohort does not). A published commentary exists specifically on this question (Wilson, "Rethinking neurobehavioral comorbidity in Panayiotopoulos syndrome", PMID:31909486).

Suggested HP terms for this cluster: - Specific learning disability — HP:0001328 - Impaired visuospatial constructive cognition — HP:0010794 - Attention deficit hyperactivity disorder — HP:0007018 (weakly supported; Akca Kalem found no behavioral excess) - Anxiety — HP:0000739 (internalizing problems, PMID:32608507)

3.4 Onset, severity, progression

  • Age of onset: 3–6 years in ~70%; full range 1–14 years (ILAE syndrome page). Specchio: "Age at onset ranged from 1.1 to 8.6 years, and was earlier in children with more than one seizure" (PMID:20528983). Caraballo: "PS had a peak age at onset of 5 years" (PMID:17442007). Değerliyurt: "Seizures started before the age of eight in 87% of the patients, and the mean age at seizure onset was 4.6 years" (PMID:24840752).
  • Severity: individually dramatic, cumulatively mild. Single seizures are frightening and often prolonged, but total seizure burden is low.
  • Progression: episodic and self-limiting. Not progressive. ILAE: "Seizures usually remit in 1-2 years."
  • Seizure count: ILAE: "Seizure frequency is usually low, 25% of children have only a single seizure and most children have ≤5 seizures in total." Caraballo (PMID:17442007): "Eighty-four (44.2%) had a single seizure, 79 (41.2%) had 2-5 fits, and 28 (14.6%) had frequent seizures." Tedrus (PMID:17057874): "Fourteen children (38.8%) had a single seizure."

3.5 Quality of life impact

Limited direct evidence. No SeLEAS-specific EQ-5D, SF-36, PROMIS, or QOLCE study exists. What is available:

  • The dominant QoL burden is diagnostic, not seizure-related. Graziosi et al. (PMID:31369969): "a wrong diagnosis may lead to inappropriate interventions. The consequences are high morbidity, costly mismanagement, and stress for children and their parents." Covanis (PMID:16950946) echoes: "The consequence is avoidable misdiagnosis, high morbidity, and costly mismanagement." Children are subjected to lumbar punctures, empiric aciclovir, ICU admission, and repeated imaging for a condition that requires none of it.
  • Academic impact (PMID:32608507): reading and arithmetic speed lag by 8–11 school months; "Mild-to-severe academic underachievement was present in more than half of the children with Panayiotopoulos syndrome."
  • A single lateralization-based QoL study in childhood epilepsy (not SeLEAS-specific) found right-hemispheric foci associated with worse anxiety/social/stigma scores (PMID:20716372) — mark as indirect.
  • A pilot exercise-therapy trial in the sibling syndrome BECTS (PMID:25025685) showed improvement in internalizing behavioral problems and mood-related well-being; not performed in SeLEAS.

4. Genetic / Molecular Information

Causal genes

NONE ESTABLISHED. This is the correct curation, and it should be stated affirmatively rather than left blank. Authoritative statement (ILAE, epilepsydiagnosis.org, June 2024): "There are no established genes, outside of rare case reports, and no clear indication to perform genetic testing."

Candidate / reported genes

Gene HGNC Evidence Relationship type Strength
SCN1A hgnc:10585 One large GEFS+ family: c.2624C>A, p.Thr875Lys, heterozygous missense, 88% penetrance, 4 members with PS phenotype (PMID:28192756). Plus three prior case reports acknowledged in that paper: "There are, however, three reports of SCN1A variants in Panayiotopoulos syndrome." SUSCEPTIBILITY / COOPERATING (not causal for the syndrome) Weak-moderate; single family + case reports
GRIN2B hgnc:4586 Null variant, de novo, in the broader self-limited focal epilepsy cohort — but associated with atypical Rolandic epilepsy, not SeLEAS specifically (PMID:32600977) Candidate, other syndrome in spectrum Weak, indirect
CAMK2A hgnc:1460 Missense, de novo, same cohort, atypical presentations (PMID:32600977) Candidate, indirect Weak
CACNG2 hgnc:1406 Splice-site substitution, "good candidate" in same cohort (PMID:32600977) Candidate, indirect Weak
GRIN2A hgnc:4585 Established for the epilepsy-aphasia continuum (ECSWS/LKS/atypical Rolandic), not for SeLEAS. The Rudolf cohort explicitly pre-screened GRIN2A-negative patients Related-syndrome gene; exclude from SeLEAS causal set N/A
SCN2A hgnc:10588 Established for self-limited familial neonatal-infantile epilepsy (PMID:23622206), not SeLEAS Related-syndrome gene N/A

The critical framing sentence from the exome study (Rudolf et al., PMID:32600977): "Our results further illustrate the fact that atypical SFEC are more likely to have Mendelian inheritance than typical SFEC." In other words — the more the child looks like textbook SeLEAS, the less likely a gene will be found. This should be recorded as a curation-relevant principle, not just a result.

Variant classification, type, allele frequency, origin, functional consequence

  • Classification: the SCN1A p.Thr875Lys variant is reported as pathogenic (PMID:28192756); no other variant is classified for this syndrome. No ClinVar assertion set exists for "Panayiotopoulos syndrome" as a condition.
  • Type: missense (SCN1A); the candidate set includes null, missense, and splice-site variants.
  • Allele frequency: NOT AVAILABLE — no population-frequency analysis has been performed against a SeLEAS phenotype.
  • Somatic vs germline: all reported variants are germline. No somatic/mosaic mechanism has been proposed.
  • Functional consequence: for SCN1A, the GEFS+ mechanism is generally loss of function of Nav1.1 in GABAergic interneurons producing disinhibition — but this is extrapolated from GEFS+/Dravet biology, not demonstrated for the SeLEAS phenotype. Mark as inference.

Modifier genes

NOT AVAILABLE. No modifier gene has been identified. Because SeLEAS remits regardless, there is no severity gradient to map modifiers against.

Epigenetic information

NOT AVAILABLE. No methylation, histone-modification, or chromatin study exists for SeLEAS. Rudolf et al. (PMID:32600977) noted "missense variants in genes encoding enzymes involved in chromatin remodeling" among candidates in atypical self-limited focal epilepsies — a hint, not a finding.

Chromosomal abnormalities

NOT AVAILABLE / negative. No recurrent CNV, translocation, or aneuploidy is associated. Chromosomal microarray is not indicated for typical SeLEAS.

5. Environmental Information

  • Environmental factors: NOT AVAILABLE. No toxin, radiation, pollution, or occupational exposure has been linked.
  • Lifestyle factors: NOT AVAILABLE. No dietary, smoking (obviously), alcohol, or activity association. Sleep is a precipitant of individual seizures (two-thirds occur in sleep, PMID:16950946), and sleep deprivation activates the EEG abnormality (ILAE EEG page) — curate these as seizure precipitants, not disease-causing environmental factors.
  • Infectious agents: NOT AVAILABLE as cause. The clinically important relationship is the reverse: SeLEAS is repeatedly mistaken for CNS infection. Covanis (PMID:16950946): "The clinical features of Panayiotopoulos syndrome are frequently mistaken as nonepileptic conditions such as acute encephalitis, syncope, migraine, cyclic vomiting syndrome, motion sickness, sleep disorder, or gastroenteritis." Note also that fever is uncommon in SeLEAS and is a useful discriminator: Kawakami et al. (PMID:35153087) found fever in "all patients with acute encephalopathy (100%), but less frequently in those with PS (11%, P < 0.001)."

6. Mechanism / Pathophysiology

This is where curation needs the most discipline. There is a well-articulated, widely repeated hypothesis, and essentially no molecular data. Below is the causal chain as the field states it, with each link labelled by evidence strength.

6.1 The proposed causal chain

Trigger (upstream) → Consequence (downstream):

  1. Age-dependent, diffuse cortical hyperexcitability (maturational, cause unknown) ↓
  2. Ictal discharge of variable lobar onset — critically, not fixed to occipital cortex ↓
  3. Propagation to / engagement of the central autonomic network (insula, anterior cingulate, amygdala, hypothalamus, brainstem autonomic nuclei), which in this age group has a lower seizure threshold than cortex ↓
  4. Autonomic output discharge — emetic-center activation, sympathetic/parasympathetic imbalance, hypothalamic thermoregulatory and cardiorespiratory involvement ↓
  5. Clinical autonomic seizure: emesis, pallor, mydriasis, thermoregulatory and cardiorespiratory change, ictal syncope ↓
  6. Optional further cortical propagation → impaired awareness, eye deviation, hemi- or bilateral convulsions (only ~50% of seizures) ↓
  7. Age-dependent resolution of the underlying hyperexcitable state → remission by early-to-mid adolescence

6.2 Evidence for each link

Link 1 (maturational hyperexcitability) — moderate, inferential. Panayiotopoulos (PMID:15145296): "it is likely that they are due to diffuse maturation-related epileptogenicity activating susceptible-for-children emetic centers and the hypothalamus." Covanis (PMID:16950946) adds the childhood-specificity argument: "The symptoms/sequence of autonomic seizures and autonomic status epilepticus in Panayiotopoulos syndrome are specific to childhood, and they do not occur in adults." That is a strong, testable claim — the same discharge in an adult brain does not produce this phenotype.

Link 2 (variable lobar onset) — strong. Koutroumanidis (PMID:17441996): "Clinically, PS is manifested by predominantly autonomic seizures and electrographically with multifocal interictal spikes, while the few published ictal recordings have documented onsets of variable lobar topography. These typical electroclinical features do not allow straightforward assignment to a distinctive cortical area, rendering the term 'focal'—as we currently understand it—problematic." He proposes SeLEAS as a model "system epilepsy" — the epilepsy of a functional system rather than of a place. Specchio confirms with ictal data: "Onsets in five ictal EEGs were posterior or anterior-left or right" (PMID:20528983).

Link 3 (central autonomic network with lower threshold) — moderate, mostly review-level. Zontek & Paprocka (PMID:35740751) is the dedicated review: "The purpose of this review is to underline the role of central autonomic network dysfunction in the development of Panayiotopoulos syndrome, as well as the possibility of using functional imaging techniques, especially functional magnetic resonance imaging (fMRI), in the diagnostic process. These methods could be crucial for understanding the pathogenesis of PS." Note the tense: could be — the fMRI work has been proposed, not done. Tata et al. (PMID:24777033) provide comparative electroclinical support: "Panayiotopoulos syndrome differs from symptomatic occipital lobe epilepsy and has a unique low epileptogenic threshold related to particular brain circuits."

Link 4/5 (autonomic output) — strong at the descriptive level, absent at the molecular level. Every large series documents the output. Nobody has measured the mediators in SeLEAS patients specifically.

Link 7 (age-dependent remission) — strong, and now with an EEG correlate. Oguni's EEG reappraisal (PMID:37660659) maps a spatially migrating, age-locked evolution — the mechanism leaves fingerprints as it matures out:

"The interictal EEG characteristics of SeLEAS are multifocal EEG foci with age-dependent predominant locations; occipital (O) at 2-5 years old, and occipital and frontopolar (synchronous and independent O and Fp spikes) at 4-7 years old and centro-parieto-temporal (CPT) at 6-10 years old. O EEG foci evolve to multifocal EEG foci with a O-Fp or CPT predominance with age and disappear by 12∼16 years old."

That migrating focus is arguably the best single piece of mechanistic evidence in the whole literature: whatever is hyperexcitable is not anatomically fixed, and it moves on a developmental clock.

6.3 Cellular processes, molecular pathways, protein dysfunction, metabolism, immunity, tissue damage

  • Molecular pathways: NOT AVAILABLE. No KEGG/Reactome pathway has been implicated by data. If SCN1A is invoked (rare cases only), the relevant processes would be sodium-channel-dependent action potential generation and interneuron-mediated inhibition.
  • Cellular processes: inferred only — excitation/inhibition imbalance in cortical and subcortical circuits.
  • Protein dysfunction: NOT AVAILABLE except in the rare SCN1A families.
  • Metabolic changes: NOT AVAILABLE. No metabolic abnormality; metabolic disease is in fact a differential diagnosis to exclude (ILAE lists "metabolic disorders (especially mitochondrial)" as a differential).
  • Immune involvement: NOT AVAILABLE / not implicated. SeLEAS is not autoimmune. (For contrast, one pediatric study found elevated anti-GAD antibodies in children with encephalitis and status epilepticus — PMID:22964438 — but this concerns the differential-diagnosis population, not SeLEAS.)
  • Tissue damage mechanisms: NONE. This is a positive, important finding for the entry. Covanis (PMID:16950946): "Autonomic status epilepticus imparts no residual neurologic deficit." Specchio (PMID:20528983) confirms that prolonged seizures do not worsen outcome: "More than half (55%) of seizures were longer than 30 min but these did not appear to affect remission and number of seizures." SeLEAS is one of the few conditions in which >30-minute status epilepticus is repeatedly shown to be harmless.
  • Biochemical abnormalities: NOT AVAILABLE. No enzyme deficiency, no receptor defect, no established channelopathy.
  • Epigenetic changes: NOT AVAILABLE.

6.4 Molecular profiling and advanced technologies

ALL NOT AVAILABLE. No transcriptomics, proteomics, metabolomics, lipidomics, single-cell, spatial, multi-omics, or CRISPR/RNAi screen has been performed on SeLEAS. GEO/ArrayExpress/PRIDE/MetaboLights contain no SeLEAS-specific dataset. This should be curated as an explicit knowledge gap, not silently omitted.

The one emerging quantitative biomarker is electrophysiological, not molecular. Fujita et al. (PMID:37918221) studied scalp-recorded high-frequency oscillations:

"Thirteen patients (72.2%) had HFOs while five patients (27.8%) had no HFOs in 194 interictal EEG records. … the seizure activity period of the HFOPG was significantly longer than that of the HFONG. Patients with an HFO duration longer than 2 years were intractable to treatment. In most cases, seizures did not occur in the absence of HFOs, even when the spikes remained. … We propose that HFOs are a biomarker of epileptogenicity and an indicator for drug reduction because seizures did not occur if HFOs disappeared even if the spikes remained."

6.5 Suggested ontology terms for mechanism nodes

GO biological processes (verified via OLS4; use with modifier since none are defective in a demonstrated sense):

Term ID Suggested modifier Use for
neuronal action potential GO:0019228 INCREASED Cortical hyperexcitability node
regulation of postsynaptic membrane potential GO:0060078 ABNORMAL E/I imbalance node
gamma-aminobutyric acid signaling pathway GO:0007214 DECREASED Inhibitory failure (inferred)
glutamate receptor signaling pathway GO:0007215 INCREASED Excitatory drive (inferred)
sodium ion transmembrane transport GO:0035725 ABNORMAL SCN1A-related cases only

CL cell types (all inferred, not demonstrated — flag as such): - cerebral cortex neuron — CL:0010012 - pyramidal neuron — CL:0000598 - GABAergic interneuron — CL:0011005 - astrocyte — CL:0000127 (speculative; include only if a mechanism node requires it)

7. Anatomical Structures Affected

Organ level

  • Primary organ: brain — UBERON:0000955. Specifically cerebral cortex — UBERON:0000956.
  • Body systems involved: central nervous system (primary); autonomic nervous system (the functional target); cardiovascular and gastrointestinal systems (as autonomic output organs, not as sites of disease).
  • Secondary organ involvement: none structurally. Heart and lungs are affected only transiently and functionally during seizures (bradycardia, apnea, in exceptional cases arrest).

Regional / tissue level

Structure UBERON Role Evidence strength
Occipital lobe UBERON:0002021 Most frequent site of interictal spikes and of the earliest age-related focus; historically (mis)taken as the seat of the syndrome Strong for EEG localization; weak as the mechanistic origin — Ferrie consensus explicitly reclassified PS as "an autonomic epilepsy, rather than an occipital epilepsy" (PMID:16483404)
Insular cortex UBERON:0034891 Central autonomic network hub; electrical stimulation elicits autonomic seizures Inferred from stimulation/insular-epilepsy literature (PMID:28644201), not from SeLEAS patients
Anterior cingulate cortex UBERON:0009835 Central autonomic network hub Inferred
Amygdala UBERON:0001876 Limbic autonomic node Inferred
Hypothalamus UBERON:0001898 Explicitly named by Panayiotopoulos as a target: "activating susceptible-for-children emetic centers and the hypothalamus" (PMID:15145296) Moderate (hypothesis, named in primary source)
Brainstem UBERON:0002298 Autonomic/cardiorespiratory nuclei; the presumed final common output Inferred
Nucleus of the solitary tract UBERON:0009050 Visceral afferent relay, emetic circuitry Inferred
Area postrema UBERON:0002162 Chemoreceptor trigger zone / emetic center candidate Inferred
Frontopolar and centro-parieto-temporal cortex (subregions of UBERON:0000956) Later age-dependent EEG foci (Oguni, PMID:37660659) Strong for EEG

For general context on the network, Edlow et al. (PMID:26530629) mapped the human central homeostatic network structurally: "interconnected brainstem and forebrain nodes form an integrated central homeostatic network (CHN) in the human brain." This is a healthy-adult connectome study, not SeLEAS — cite as background only.

Cell and subcellular level

  • Cell populations: not demonstrated. See §6.5 for inferred CL terms.
  • Subcellular compartments: NOT AVAILABLE. No GO Cellular Component involvement has been established. If SCN1A cases are modeled, plasma membrane / axon initial segment would apply — mark as inference.

Localization and lateralization

  • Multifocal and shifting — the defining spatial property. ILAE EEG page: "Multifocal high voltage spikes or sharp-waves are typically seen, these often are present in different focal areas on sequential EEGs. All focal brain regions may be affected but abnormality is often over the posterior (occipital) regions."
  • Bilateral involvement over time, unilateral per event. ILAE: "Ictal patterns are unilateral, often having posterior onset."
  • Persistent unifocal abnormality is an ILAE ALERT criterion — i.e. a focus that stays put suggests a structural lesion, not SeLEAS.

8. Temporal Development

Onset

  • Typical age: 3–6 years (~70% of cases); range 1–14 years (ILAE syndrome page).
  • Peak: 5 years (PMID:17442007); mean 4.6 years (PMID:24840752).
  • Onset pattern: acute/paroxysmal at the level of the individual seizure; the epilepsy itself begins abruptly with a first, often dramatic and prolonged, event. There is no prodrome and no insidious phase.
  • Earlier onset predicts more seizures: "Age at onset ranged from 1.1 to 8.6 years, and was earlier in children with more than one seizure" (PMID:20528983).

Progression and course

  • Course pattern: episodic, self-limited. Not progressive, not relapsing-remitting in the immunological sense.
  • Total duration of active epilepsy: typically 1–2 years (ILAE syndrome page).
  • Remission: spontaneous and age-determined. ILAE course-of-illness criterion: "Remission by early to mid adolescence. No regression." ILAE clarifies the term: "Self-limiting refers to there being a high likelihood of seizures spontaneously remitting at a predictable age."
  • EEG normalizes later than the clinical course: spikes "disappear by 12∼16 years old" (PMID:37660659) — expect EEG abnormality to outlast seizures, and do not treat the EEG.
  • Recurrence kinetics (Specchio, PMID:20528983): "Cumulative probability of recurrence was 57.6%, 45.6%, 35.1%, and 11.7% at 6, 12, 24, and 36 months, respectively, after the first seizure." — a clean, curatable natural-history curve.

Evolution to other syndromes

  • To SeLECTS (Rolandic epilepsy): ILAE: "Some patients may evolve to have self-limited epilepsy with centrotemporal spikes." Caraballo (PMID:17442007): "Sixteen children had concomitant symptoms of rolandic epilepsy and eight developed rolandic seizures after remission of PS seizures."
  • To DEE-SWAS / electrical status epilepticus in sleep — rare but the key adverse outcome. Değerliyurt (PMID:24840752): "Evolution to electrical status epilepticus in sleep and Gastaut-type epilepsy were seen in patients with more than ten seizures." Oguni (PMID:37660659): "O-Fp EEG foci may further evolve to generalized spike-wave complexes and rarely to spike-wave activated in sleep." Semprino (PMID:35063695) reports one such patient. Per ILAE, "Regression with spike-wave activation in sleep (consider DEE-SWAS)" is both an ALERT and a course-of-illness EXCLUSIONARY criterion.
  • Mixed PS/Gastaut phenotypes are common. Taylor et al. (PMID:18669497): "One-third of the children in this selected series of BOEC did not have a pure syndrome, rather a mixed syndrome with features of both Panayiotopoulos and Gastaut syndromes. … BOEC is an electro-clinical spectrum with Panayiotopoulos and Gastaut syndromes at either end."

Critical periods

The 3–6 year window is the vulnerability period; adolescence is the resolution period. There is no intervention window in the disease-modifying sense — treatment does not alter the timeline. Specchio (PMID:20528983): "Thirty-four (58.6%) of 59 patients treated with antiepileptic drugs continued having seizures before ultimate remission."

9. Inheritance and Population

Epidemiology

Two very different-looking numbers circulate, and they measure different things. Curate both, clearly separated.

Proportion of childhood afebrile seizures (a fraction, not a rate):

Covanis (PMID:16950946): "Panayiotopoulos syndrome probably affects 13% of children aged 3 to 6 years who have had 1 or more afebrile seizures and 6% of such children in the 1- to 15-year age group." Panayiotopoulos (PMID:15145296) gives the same figures: "They probably affect approximately 13% of children aged 3-6 years with one or more nonfebrile seizures, or 6% in the age group 1-15." Graziosi (PMID:31369969) restates: "a frequent (6% among children of 1-15 years) and benign epileptic syndrome."

Specchio's consecutive-referral series gives a slightly lower, arguably cleaner figure (PMID:20528983): "Of 1,794 children aged between 1 and 14 years referred for the first afebrile focal seizure, between January 1992 and December 2004, 93 (5.2%) had PS according to clinical criteria."

Population incidence (an actual rate):

Weir et al. (PMID:29571057), the only population-based study: "The incidence of PS and BECTS was found to be 0.8 and 6.1 per 100,000 <16 year olds, respectively. … The findings suggest BECTS is eight times more common than PS and that the incidence of PS is lower than previously suggested."

For dismech Prevalence records, this maps to:

population measure_type prevalence_class rate_per_100000 source
Children <16 y, NW England & N Wales ANNUAL_INCIDENCE BAND_1_9_PER_1000000 0.8 PMID:29571057
Children aged 1–15 y with afebrile seizures (case fraction, not a population rate — do not encode as prevalence) — — PMID:16950946

⚠ Curation warning: the widely-quoted "6%" and "13%" are case fractions among children with afebrile seizures, not population prevalence. Encoding them in a Prevalence record with population: Worldwide would be a category error. Put them in notes or model them as a diagnostic-yield statistic.

UK caseload estimate for planning purposes (Mellish et al., PMID:25202134): "We estimated, annually, 751 new RE cases and 233 PS cases" in the UK.

For genetic etiology

  • Inheritance pattern: multifactorial / complex. No Mendelian pattern. ILAE: "there is no classical inheritance pattern." HPO mode-of-inheritance term: consider HP:0010982 (Polygenic inheritance) with relationship_type: SUSCEPTIBILITY for any gene, or leave inheritance unbound and describe in prose. Do not assert autosomal dominant.
  • Penetrance: N/A for the syndrome. For the one SCN1A family, penetrance of any GEFS+-spectrum phenotype was 88% (16/18), but only 4/18 had the PS phenotype — i.e. penetrance for this specific phenotype was ~22% (PMID:28192756).
  • Expressivity: highly variable within the one informative family — febrile seizures, FS+, atypical BECTS, and PS all segregated with the same variant.
  • Genetic anticipation: NOT AVAILABLE / not applicable (no repeat expansion mechanism).
  • Germline mosaicism: NOT AVAILABLE.
  • Founder effects: NOT AVAILABLE.
  • Consanguinity: no established role.
  • Carrier frequency: NOT APPLICABLE (no recessive mechanism).
  • Family history rates: ILAE: "There is a higher prevalence of febrile seizures in first degree relatives and case reports of siblings with other self-limited focal epilepsies of childhood." In the related BECTS comparison cohort, 9.8% of first-degree relatives had seizures (PMID:23294109).

Population demographics

  • Sex ratio: 1:1. ILAE: "Both sexes are affected equally." (Contrast with the epilepsy-aphasia spectrum, where male predominance is seen — PMID:23294109.)
  • Ethnic/geographic distribution: no population is known to be over- or under-represented. The syndrome has been described in large series from Argentina (n=192, PMID:17442007), Italy (n=93, PMID:20528983), Turkey (n=38, PMID:24840752; n=24, PMID:24777033), Japan (PMID:37660659, PMID:35153087), Brazil (n=36, PMID:17057874), the Netherlands (PMID:32608507), the UK (PMID:29571057), India (PMID:18515936), Saudi Arabia (PMID:21822089), and Germany (PMID:42348808). Panayiotopoulos (PMID:15145296) noted it "has been confirmed worldwide in more than 800 cases." This global spread with no reported hotspot is itself weak evidence against a founder variant.
  • Age distribution of affected individuals: essentially all prevalent cases are aged ~1–16 years. Adults do not have this syndrome — Covanis (PMID:16950946) is explicit: the autonomic seizure sequence "do[es] not occur in adults."

10. Diagnostics

10.1 ILAE 2022 diagnostic criteria (verbatim from epilepsydiagnosis.org, CC BY-SA 4.0, text last updated 2024-06-30)

Domain MANDATORY ALERTS EXCLUSIONARY
Seizures Focal autonomic seizures Seizure frequency greater than monthly —
EEG High amplitude focal or multifocal epileptiform abnormality that increases in drowsiness and sleep Sustained focal slowing (outside the postictal period); persistent unifocal abnormality —
Age at onset — 8 years 14 years
Development at onset — Moderate or greater impairment Regression with spike-wave activation in sleep (consider DEE-SWAS)
Neurological exam — Abnormal exam —
Imaging — — Structural cause for the epilepsy
Course of illness Remission by early to mid adolescence; no regression — Regression with spike-wave activation in sleep (consider DEE-SWAS)

Additional ILAE notes, verbatim:

"An MRI is not mandatory for diagnosis but should be considered in the presence of any alerts" "An ictal EEG is not required" "Syndrome without laboratory confirmation: in resource-limited regions, an interictal EEG is required to diagnose this syndrome" "Alert criteria are absent in the vast majority of patients with the syndrome, but rarely can be seen. Their presence should result in caution in diagnosing the syndrome and consideration of other conditions"

10.2 Electrophysiology — EEG (the only positive test)

Covanis (PMID:16950946): "An electroencephalogram is the only investigation with abnormal results, usually showing multiple spikes in various brain locations."

ILAE EEG description (verbatim): - Background: "The background EEG is normal." Caution: "Focal slowing consistently over one area is not seen — consider structural brain abnormality." - Interictal: "A standard EEG can be normal in some patients. Multifocal high voltage spikes or sharp-waves are typically seen, these often are present in different focal areas on sequential EEGs. All focal brain regions may be affected but abnormality is often over the posterior (occipital) regions." - Activation: "EEG abnormality is enhanced by sleep deprivation, in drowsiness and in sleep, when discharges often have a wider field and may be bilaterally synchronous. Eye closure (elimination of central vision and fixation off sensitivity) may activate posterior discharges in some patients." - Ictal: "Ictal patterns are unilateral, often having posterior onset, with rhythmic slow (theta or delta) activity intermixed with small spikes and/or fast activity."

Quantitative EEG findings from cohorts: - Multifocal epileptiform discharges: 79.5% (PMID:20528983), 84% (PMID:24840752) - Occipital spikes: 75%; rolandic spikes also present in 25%; normal EEG in 16.6% (PMID:17057874) - Consistently normal EEG: 5.4%; background abnormality only: 16.1% (PMID:20528983) - Non-REM sleep activation in both PS and symptomatic occipital epilepsy; in PS the spikes "tended to spread mainly to central and centro-temporal regions" (PMID:24777033) - Age-dependent spatial migration (PMID:37660659): occipital at 2–5 y → occipital + frontopolar at 4–7 y → centro-parieto-temporal at 6–10 y → gone by 12–16 y. Oguni proposes: "O-Fp EEG foci may be a specific EEG pattern indicating a diagnosis of SeLEAS." - Emerging: interictal scalp HFOs as an activity biomarker (PMID:37918221) — 72.2% HFO-positive; HFO duration >2 years predicted treatment-refractoriness; "seizures did not occur if HFOs disappeared even if the spikes remained."

NCIT term: Electroencephalography — NCIT:C38054

10.3 Imaging

Normal, and often unnecessary. ILAE: "Neuroimaging is normal. If the clinical presentation and EEG is typical for this syndrome, imaging is not required."

Mellish et al. (PMID:25202134) documented over-imaging in UK practice: "MRI brain at least half the time in 40%-65% cases … Management among respondents is broadly in line with national guidance, although with possible overuse of brain imaging and underuse of EEG and neuropsychological assessments."

NCIT term: Magnetic Resonance Imaging — NCIT:C16809

10.4 Laboratory tests, biomarkers, biopsy, pathology

ALL NORMAL / NOT AVAILABLE. There is no blood, urine, CSF, or tissue abnormality. No biomarker exists. No histopathology exists (no one biopsies this). The main laboratory issue is avoiding unnecessary invasive testing — see the misdiagnosis literature below.

10.5 Genetic testing

Not indicated for typical cases. ILAE: "There are no established genes, outside of rare case reports, and no clear indication to perform genetic testing."

Reasonable exceptions, based on Rudolf et al.'s finding that "atypical SFEC are more likely to have Mendelian inheritance than typical SFEC" (PMID:32600977): - Atypical presentation (regression, spike-wave activation in sleep, drug resistance, alert criteria present) → epilepsy gene panel or WES may be considered, including SCN1A and GRIN2A. - Strong family history of GEFS+-spectrum phenotypes → SCN1A testing may be considered (PMID:28192756). - WGS, CMA, karyotype, FISH, mtDNA testing, repeat expansion testing: not indicated.

10.6 Omics-based diagnostics

NONE AVAILABLE OR INDICATED. No RNA-seq, proteomic, metabolomic, epigenomic, or liquid-biopsy assay is used or under development for SeLEAS.

10.7 Differential diagnosis

ILAE list (verbatim): - "Focal autonomic seizures due to structural brain abnormality" - "Migraine associated disorders including benign paroxysmal vertigo" - "Disorders associated with intermittent encephalopathy e.g. metabolic disorders (especially mitochondrial)" - "Disorders associated with intermittent vomiting e.g. gastrointestinal disorders"

Extended literature list with distinguishing features:

Mimic Distinguishing features Source
Acute encephalitis / encephalopathy Fever present in 100% of encephalopathy vs 11% of PS; convulsions ≥15 min in 90% vs 17%; PS seizures stop with midazolam 0.1 mg/kg while encephalopathy needs ≥0.3 mg/kg; vomiting 78% (PS) vs 3% PMID:35153087
Migraine / childhood headache Best-quantified mimic. In 186 children referred for "migraine"/"headache", "18.8% (n = 35) of pediatric patients initially diagnosed with 'migraine' or 'headache' received a possible, probable, or definite diagnosis of benign focal epilepsy with autonomic seizures"; 6.5% received a definite SeLEAS diagnosis PMID:42348808
Syncope (cardiogenic/vasovagal) Ictal syncope in PS is accompanied by other autonomic features and often follows emesis PMID:16950946
Cyclic vomiting syndrome / gastroenteritis / GERD PS has associated eye deviation, impaired awareness, EEG spikes PMID:31369969, PMID:16950946
Motion sickness, sleep disorders, metabolic disease Listed mimics PMID:16950946, PMID:17464469
Gastaut syndrome (childhood occipital visual epilepsy) Later onset, brief seizures, prominent visual symptoms (visual symptoms in only ~5% of PS), postictal headache; neuropsychologically distinguishable (PS worse on performance IQ, visual memory, reading) PMID:31398558, PMID:24840752
Symptomatic occipital lobe epilepsy Earlier onset (3.4 vs 5.6 y), fewer autonomic seizures (43.5% vs 87.5%), less ictal syncope (13% vs 37.5%), lesion on MRI PMID:24777033

The framing sentence for the entry (Parisi et al., PMID:17464469): "The peculiar aspects should be known not only by epileptologists but also by general doctors because a correct diagnosis would avoid aggressive interventions and concerns on account of its benign outcome."

10.8 Screening

NOT APPLICABLE. No newborn screening, carrier screening, or cascade screening exists or is warranted. Graziosi et al. (PMID:31369969) do make a service-level suggestion: "The availability of electroencephalography (EEG) recording in pediatric Emergency Departments might be useful for a prompt and not-cost-consuming diagnosis."

11. Outcome / Prognosis

Survival and mortality

  • Life expectancy: normal. No excess mortality attributable to SeLEAS has been demonstrated in any cohort.
  • Disease-specific mortality: no deaths from SeLEAS are reported in the major series (Caraballo n=192, Specchio n=93, Değerliyurt n=38, Tedrus n=36 — zero deaths across all).
  • The one theoretical risk is ictal cardiorespiratory arrest. Covanis (PMID:16950946): "Cardiorespiratory arrest is exceptional" and "autonomic seizures are potentially life-threatening in the rare context of cardiorespiratory arrest, an area in which additional study is required."
  • Mujawar et al. (PMID:21822089): "ictal cardiorespiratory arrest is extremely rare, with only 4 cases being reported in literature. All 4 cases reported in literature recovered spontaneously and did not require resuscitation. Here we present a 3½-year-old male child with Panayiotopoulos syndrome who presented with status epilepticus and ictal cardiorespiratory arrest requiring cardiopulmonary resuscitation for revival."
  • Yamamoto et al. (PMID:29926008), a 10-year-old resuscitated after ictal cardiac arrest: "Lifethreating cardiopulmonary arrest is rare in PS, but long seizure duration of PS may associate with apnea and bradycardia."
  • Semprino et al. (PMID:35063695): 2/44 patients in an atypical-presentation series — "Two children (4.8%) had their first seizure while asleep associated with cardiorespiratory arrest." Note the denominator is enriched for atypia.
  • A second, iatrogenic mortality pathway is explicitly flagged. Covanis (PMID:16950946): "Autonomic status epilepticus in the acute stage needs thorough evaluation; aggressive treatment may cause iatrogenic complications including cardiorespiratory arrest." Over-treating this condition can hurt the child more than the condition does. This belongs in the entry as a treatment-safety node.

Morbidity and function

  • No residual neurological deficit. Covanis (PMID:16950946): "Autonomic status epilepticus imparts no residual neurologic deficit."
  • Risk of adult epilepsy is not elevated. Covanis: "The risk of epilepsy in adult life seems to be no higher than in the general population."
  • Possible mild cognitive/academic morbidity — see §3.3. Contested. The strongest claim (PMID:32608507): "Mild-to-severe academic underachievement was present in more than half of the children with Panayiotopoulos syndrome." The largest cohort (PMID:20528983) does not support clinically meaningful impairment.
  • QoL measures: no disease-specific instrument data. See §3.5.

Disease course and complications

  • Complications: autonomic status epilepticus (common, benign); evolution to DEE-SWAS or Gastaut syndrome (rare, associated with >10 seizures — PMID:24840752); ictal cardiorespiratory arrest (exceptional); misdiagnosis-driven iatrogenic harm (common and underappreciated).
  • Recovery potential: complete, with or without treatment. Mujawar (PMID:21822089): "Recovery from this autonomic status epilepticus is within hours and is always complete."

Prognostic factors

Factor Direction Source
Earlier age at onset → more seizures PMID:20528983
>10 lifetime seizures → risk of evolution to ESES / Gastaut syndrome PMID:24840752
Seizure duration >30 min → no effect on remission or seizure count (i.e. not prognostic) PMID:20528983
Interictal HFO duration >2 years → treatment refractoriness PMID:37918221
HFO disappearance → seizure freedom even with persisting spikes; candidate drug-withdrawal indicator PMID:37918221
Alert criteria present (abnormal exam, developmental impairment, focal slowing, persistent unifocal spikes) → reconsider the diagnosis ILAE 2022

Overall summary (Specchio, PMID:20528983): "PS is a uniform childhood susceptibility to autonomic seizures that is related to early age of development and with excellent prognosis with regard to seizure remission and neuropsychological development."

12. Treatment

12.1 The central treatment fact: often, no treatment

Covanis (PMID:16950946): "Education about Panayiotopoulos syndrome is the cornerstone of management. Prophylactic treatment with antiepileptic medication may not be needed for most patients."

Vigevano et al. (PMID:23622206), on self-limited focal epilepsies generally: "These entities are age-dependent and seizures tend to disappear spontaneously. For these reasons often the drug treatment is not necessary."

UK practice reality (Mellish et al., PMID:25202134): "Clinicians reported non-treatment in 40%: main reasons were low frequency of seizures and parent/child preferences."

Efficacy caveat — treatment does not reliably prevent seizures either (Specchio, PMID:20528983): "Thirty-four (58.6%) of 59 patients treated with antiepileptic drugs continued having seizures before ultimate remission." And most patients who are treated need only one drug (Değerliyurt, PMID:24840752): "Two or more antiepileptic drugs were required in only 13% of the patients."

12.2 Pharmacotherapy

⚠ There is no randomized controlled trial of any drug in SeLEAS. Drug choice is by clinician preference and extrapolation from focal epilepsy. Mellish et al. (PMID:25202134) surveyed UK preference explicitly to design a future trial: "Carbamazepine is the preferred older, and levetiracetam the preferred newer, RCT arm."

Treatment treatment_term (NCIT) therapeutic_agent (CHEBI verified) therapeutic_modality Evidence
Carbamazepine Pharmacotherapy — NCIT:C15986 carbamazepine — CHEBI:3387 SMALL_MOLECULE Preferred older agent, UK survey (PMID:25202134)
Levetiracetam Pharmacotherapy — NCIT:C15986 levetiracetam — CHEBI:6437 SMALL_MOLECULE Preferred newer agent, UK survey (PMID:25202134)
Oxcarbazepine Pharmacotherapy — NCIT:C15986 oxcarbazepine — CHEBI:7824 SMALL_MOLECULE Common practice; no SeLEAS-specific evidence
Valproic acid Pharmacotherapy — NCIT:C15986 valproic acid — CHEBI:39867 SMALL_MOLECULE Common practice; no SeLEAS-specific evidence
Clobazam Pharmacotherapy — NCIT:C15986 clobazam — CHEBI:31413 SMALL_MOLECULE Practice; no SeLEAS-specific evidence
Sultiame Pharmacotherapy — NCIT:C15986 Sultiame — CHEBI:32171 SMALL_MOLECULE Used in European practice for self-limited focal epilepsies
Midazolam (acute/rescue) Pharmacotherapy — NCIT:C15986 midazolam — CHEBI:6931 SMALL_MOLECULE Best-supported acute intervention — see below
Diazepam (rescue) Pharmacotherapy — NCIT:C15986 diazepam — CHEBI:49575 SMALL_MOLECULE Standard home rescue for prolonged seizures

Alternative generic term: Anticonvulsant Therapy — NCIT:C64172; Anticonvulsant Agent — NCIT:C264.

The one quantitatively supported acute-treatment finding (Kawakami et al., PMID:35153087): "seizures were treatable in all patients with PS with a small dose of midazolam (0.1 mg/kg), but all patients with acute encephalopathy required midazolam at 0.3 mg/kg or more (P < 0.001)." This doubles as a therapeutic and a diagnostic observation — SeLEAS status is unusually benzodiazepine-responsive.

Safety flag for sodium-channel blockers. Pasini et al. (PMID:35151939) report iatrogenic ictal asystole with carbamazepine and phenytoin: "The clear relationship between ictal arrhythmia and sodium channels blockers may be related to the negative chronotropic and inotropic cardiac effects." Given that SeLEAS already carries a rare ictal-bradycardia/asystole risk, this interaction deserves an explicit note — the cases were in pharmacoresistant focal epilepsy, not SeLEAS, so mark as an extrapolated caution.

12.3 Management of autonomic status epilepticus

Ferrie et al.'s consensus definition (PMID:17442005) is the reference standard:

"Autonomic SE is a condition lasting at least 30 min and characterized by epileptic activity causing altered autonomic function of any type at seizure onset or in which manifestations consistent with altered autonomic function are prominent (quantitatively dominant or clinically important) even if not present at seizure onset. It is best described, and probably most commonly encountered in children, with Panayiotopoulos syndrome. … Its pathogenesis and most appropriate management are poorly understood."

Management principles: evaluate thoroughly, treat gently. Covanis (PMID:16950946): "Autonomic status epilepticus in the acute stage needs thorough evaluation; aggressive treatment may cause iatrogenic complications including cardiorespiratory arrest."

12.4 Pharmacogenomics

NOT AVAILABLE for SeLEAS specifically. The general pediatric epilepsy PGx caveats apply: HLA-B*15:02 screening before carbamazepine in at-risk ancestries (CPIC), and CYP2C9/CYP2C19 effects on phenytoin and valproate metabolism. None is SeLEAS-specific.

12.5 Advanced therapeutics

ALL NOT APPLICABLE. No gene therapy, cell therapy, RNA-based therapy, targeted therapy, or immunotherapy is under development or would be justified for a condition that remits on its own within 1–2 years.

12.6 Surgical and interventional

NOT INDICATED. Epilepsy surgery has no role. The syndrome has no resectable focus (the foci shift), no lesion, and self-resolves. (For context on when surgery is considered in other pediatric epilepsies, see PMID:34620459 — SeLEAS is not among them.)

12.7 Supportive, rehabilitative, and educational

Intervention NCIT term ID Rationale
Patient/family education Patient Education NCIT:C16959 "Education about Panayiotopoulos syndrome is the cornerstone of management" (PMID:16950946) — this is arguably the primary treatment
Supportive care Supportive Care NCIT:C15747 Seizure action plan, rescue medication training, positioning/airway during prolonged seizures
Neuropsychological assessment (no clean NCIT clinical-action term; use free-text preferred_term) — Underused per PMID:25202134 ("neuropsychological evaluation in 7%-8%"); warranted given the cognitive-comorbidity literature
Educational/academic support (no NCIT term; free text) — Justified by PMID:32608507 (8–11 month academic lag), PMID:26709104
Genetic counseling Genetic Counseling NCIT:C15240 Rarely indicated; only for atypical/familial cases

12.8 Experimental treatments and clinical trials

NO REGISTERED TRIALS. A ClinicalTrials.gov API v2 query (query.cond=Panayiotopoulos and query.term=Panayiotopoulos, retrieved 2026-08-05) returned zero studies. Curate clinical_trials: as empty and note the absence explicitly — it is informative, not an omission.

Mellish et al. (PMID:25202134) exist precisely to argue this gap should be closed: "Considerable international variation in management and controversy about non-treatment indicate the need for high quality randomised controlled trials (RCT)… Approximately one-half considered active and placebo designs acceptable, choosing seizures as primary and cognitive/behavioural measures as secondary outcomes."

12.9 Treatment strategy

A defensible algorithm from the literature:

  1. Diagnose correctly (clinical picture + interictal EEG). Avoid LP, empiric aciclovir, ICU admission where the picture is typical.
  2. Educate the family; provide a written seizure action plan.
  3. Provide home rescue medication (benzodiazepine) for seizures lasting >5 min, given that half exceed 30 min.
  4. Withhold maintenance ASM in most children — ~40% of UK clinicians do (PMID:25202134); 25% of children have only one seizure ever (ILAE).
  5. Start maintenance ASM for frequent seizures (>monthly is an ILAE alert), multiple prolonged episodes, or high family anxiety. First-line by practice preference: carbamazepine/oxcarbazepine or levetiracetam.
  6. Withdraw after ~2 seizure-free years; consider HFO disappearance as a supporting indicator (PMID:37918221). Do not treat the EEG — spikes persist until 12–16 years.
  7. Re-evaluate the diagnosis if any ILAE alert appears, particularly regression with sleep-activated spike-wave (→ DEE-SWAS).

Personalized medicine approaches: NOT AVAILABLE. No genotype-guided treatment exists.

13. Prevention

  • Primary prevention: NOT POSSIBLE / NOT APPLICABLE. No modifiable risk factor exists.
  • Secondary prevention (early detection): the meaningful target is prevention of misdiagnosis, not prevention of disease. The concrete proposal in the literature is ED access to EEG (PMID:31369969). Berg et al. (PMID:42348808) add a second detection target: "When evaluating children and adolescents with headache, clinicians should give greater consideration to SeLEAS as a differential diagnosis than in the past, especially due to its significant therapeutic implications."
  • Tertiary prevention (complication prevention):
  • Rescue benzodiazepine to abort prolonged seizures and reduce autonomic status duration (linked to the apnea/bradycardia risk, PMID:29926008).
  • Avoiding over-aggressive acute treatment, which can itself precipitate cardiorespiratory arrest (PMID:16950946).
  • Monitoring for evolution to DEE-SWAS in children with >10 seizures (PMID:24840752).
  • Immunization: NOT APPLICABLE. No vaccine-preventable component. (There is no evidence linking vaccination to SeLEAS onset either.)
  • Screening programs / genetic screening / PGD / prenatal testing: NOT APPLICABLE. No causal gene; recurrence risk is not quantified beyond a general familial enrichment of febrile seizures.
  • Risk stratification: NOT AVAILABLE. No validated risk model.
  • Behavioral interventions: none established. A single small pilot in the sibling syndrome BECTS suggested structured exercise improved neurocognitive and internalizing-behavior outcomes (PMID:25025685) — hypothesis-generating only, not performed in SeLEAS.
  • Counseling: reassurance-focused counseling about excellent prognosis is the highest-value "preventive" act, since the documented harms of this condition are largely those of misdiagnosis and family distress.
  • Public health / environmental interventions: NOT APPLICABLE.
  • Prophylaxis: maintenance ASM is the only prophylactic option and is explicitly optional (§12).

14. Other Species / Natural Disease

NO NATURAL ANIMAL COUNTERPART IS KNOWN. This should be curated as an explicit negative.

  • Taxonomy: Homo sapiens — NCBITaxon:9606 — only.
  • Breed (VBO): NOT APPLICABLE.
  • Orthologous genes: since no causal gene exists, orthology is moot. If SCN1A is curated as a rare susceptibility gene, orthologs exist (mouse Scn1a, NCBI Gene 20265; zebrafish scn1lab), but they model Dravet/GEFS+ rather than SeLEAS.
  • Natural disease in other species: NOT AVAILABLE. No OMIA entry corresponds to SeLEAS. Idiopathic epilepsy is common in dogs (many breeds) but no canine syndrome with age-dependent autonomic/emetic seizures and spontaneous remission has been characterized as a SeLEAS analog.
  • Veterinary relevance: none.
  • Comparative pathology: NOT AVAILABLE. The barrier is conceptual as well as practical — the phenotype is defined by a developmental window and by symptoms (nausea, feeling unwell, awareness of retching) that are difficult to ascertain in an animal.
  • Evolutionary conservation of mechanism: the substrate (central autonomic network, brainstem–forebrain homeostatic circuitry) is deeply conserved (PMID:26530629 describes the human structural connectome of this network and notes species differences: "a lateral forebrain bundle, whose connectivity is distinct from that of rodents and nonhuman primates, is the primary conduit for connections between the brainstem and medial temporal lobe"). The syndrome, however, is not known to be conserved.
  • Zoonotic potential / cross-species susceptibility: NOT APPLICABLE (non-infectious).

15. Model Organisms

NO MODEL OF SeLEAS EXISTS. This is a firm negative and should be curated as one, with a KNOWLEDGE_GAP discussion attached.

Why no model exists

Three structural obstacles, worth recording because they explain the gap rather than merely noting it:

  1. No causal gene to engineer. You cannot make a knock-in without a variant.
  2. The defining feature is a developmental time-course (onset 3–6 human years, remission within 1–2 years, EEG normalization by 12–16 years). Mapping that window onto rodent development is non-trivial.
  3. The cardinal symptom is emesis, and rodents cannot vomit. Mice and rats lack the brainstem emetic reflex circuitry required for vomiting — so the single most characteristic phenotype of this syndrome is unobservable in the default mammalian model. Any model would need a ferret, shrew, or non-human primate, none of which is a practical epilepsy-genetics platform.

Adjacent models that are not models of SeLEAS

Curate these only if the entry needs a HUMAN_MODEL_MISMATCH discussion — they are relevant background, not evidence for SeLEAS mechanism:

Model Relationship Caveat
Scn1a+/− and Scn1a knock-in mice (MGI) Model GEFS+/Dravet, the spectrum into which the single SeLEAS family's variant falls (PMID:28192756) Model severe phenotypes; do not recapitulate self-limited autonomic seizures or spontaneous remission
Grin2a mouse models Model the epilepsy-aphasia continuum Explicitly a different syndrome; the SeLEAS exome cohort was GRIN2A-negative by design (PMID:32600977)
Kindling / kainate rodent models of focal epilepsy Generic focal epileptogenesis No autonomic-predominant, age-remitting phenotype

Model types, genetic models, phenotype recapitulation, applications, resources

  • Model organism type: none available (mammalian, invertebrate, cellular, and in vitro all NOT AVAILABLE).
  • Specific systems (iPSC, organoid, cell line): NOT AVAILABLE. No SeLEAS patient-derived iPSC line is registered in Cellosaurus or comparable resources.
  • Induced models: NOT AVAILABLE.
  • Genetic models (KO/KI/transgenic/conditional/humanized): NOT AVAILABLE.
  • Phenotype recapitulation: N/A.
  • Model limitations: see the three obstacles above.
  • Research applications: the tractable research substrate for SeLEAS is human electrophysiology (longitudinal EEG, HFO quantification, source localization) and human functional imaging (the fMRI approach proposed but not yet executed by Zontek & Paprocka, PMID:35740751), not animal modeling.
  • Model databases: MGI, RGD, ZFIN, IMPC, IMSR contain no SeLEAS-associated allele or phenotype annotation.

Appendix A — Summary of proposed dismech mechanistic_hypotheses

Because the mechanism is entirely hypothetical, I recommend curating it as competing hypotheses rather than a settled chain:

hypothesis_group_id Label Status Content Key evidence
maturational_autonomic_susceptibility Diffuse maturation-related epileptogenicity activating low-threshold autonomic centers CANONICAL Age-dependent diffuse cortical hyperexcitability engages emetic centers and hypothalamus; the syndrome is not occipital PMID:15145296, PMID:16950946, PMID:16483404
system_epilepsy_model SeLEAS as a "system epilepsy" of the central autonomic network rather than a lobar focal epilepsy ALTERNATIVE / complementary Variable lobar ictal onset + multifocal interictal spikes make "focal" the wrong frame; the epilepsy belongs to a functional system PMID:17441996, PMID:24777033
occipital_origin_model Early-onset benign occipital epilepsy SUPERSEDED The original 1989 framing; formally rejected by the 2006 consensus and the 2022 ILAE nomenclature PMID:16483404 (refutes), PMID:19469846 (history)

And suggested discussions:

  • KNOWLEDGE_GAP — Are cognitive and behavioral comorbidities real, or an artifact of tertiary-referral bias? (attaches to the cognitive phenotype nodes; PMID:32608507 & PMID:31398558 vs PMID:20528983; commentary PMID:31909486)
  • KNOWLEDGE_GAP — What is the molecular basis of the age-dependent hyperexcitability, and what causes remission? No omics, no model, no gene. Proposed experiments: longitudinal HFO/source-localization studies (PMID:37918221), the fMRI central-autonomic-network protocol proposed in PMID:35740751.
  • KNOWLEDGE_GAP — Which drug, if any? No RCT has ever been performed (PMID:25202134 explicitly proposes the trial design).
  • HUMAN_MODEL_MISMATCH — SCN1A mouse models exist but model Dravet/GEFS+, not SeLEAS; and rodents cannot vomit, so the cardinal phenotype is unmodellable in the standard platform.

Appendix B — Verified ontology term quick reference

All terms below were verified against live OLS4 (EBI) on 2026-08-05. Verify again with just validate-terms before committing — this list is a curation aid, not a substitute for the validator.

MONDO: MONDO:0020307 (Self-limited epilepsy with autonomic seizures)

HP: HP:0011154 · HP:0032740 · HP:0032755 · HP:0011159 · HP:0032761 · HP:0032773 · HP:0002013 · HP:0002018 · HP:0000980 · HP:0000961 · HP:0011499 · HP:0000549 · HP:0002384 · HP:0001279 · HP:0002133 · HP:0032861 · HP:0007334 · HP:0006813 · HP:0003781 · HP:0000020 · HP:0002315 · HP:0002104 · HP:0001662 · HP:0010841 · HP:0012016 · HP:0012557 · HP:0025644 · HP:0002353 · HP:0025373 · HP:0002270 · HP:0001328 · HP:0010794 · HP:0007018 · HP:0000739 · HP:0002373 (febrile seizure, for the family-history/antecedent phenotype)

GO: GO:0019228 · GO:0060078 · GO:0007214 · GO:0007215 · GO:0035725

CL: CL:0010012 · CL:0000598 · CL:0011005 · CL:0000127

UBERON: UBERON:0000955 · UBERON:0000956 · UBERON:0002021 · UBERON:0034891 · UBERON:0009835 · UBERON:0001876 · UBERON:0001898 · UBERON:0002298 · UBERON:0009050 · UBERON:0002162 · UBERON:0001759

CHEBI: CHEBI:3387 · CHEBI:6437 · CHEBI:7824 · CHEBI:39867 · CHEBI:31413 · CHEBI:6931 · CHEBI:49575 · CHEBI:32171

NCIT: NCIT:C15986 · NCIT:C64172 · NCIT:C264 · NCIT:C38054 · NCIT:C16809 · NCIT:C16959 · NCIT:C15747 · NCIT:C15240

HGNC: hgnc:10585 (SCN1A) — susceptibility only, rare families

Appendix C — Priority citations with verified abstract quotes

These are the highest-value evidence items for the entry. Every quote below is copied verbatim from the PubMed abstract as retrieved via NCBI E-utilities on 2026-08-05; each should still be run through just fetch-reference + just validate-references before committing.

PMID Short handle Best-use quote (verbatim)
16950946 Covanis 2006, Pediatrics — the single richest source "Half of the seizures in Panayiotopoulos syndrome last for >30 minutes, thus constituting autonomic status epilepticus, which is the more common nonconvulsive status epilepticus in normal children. Two thirds of seizures occur during sleep."
16950946 (epidemiology) "Panayiotopoulos syndrome probably affects 13% of children aged 3 to 6 years who have had 1 or more afebrile seizures and 6% of such children in the 1- to 15-year age group."
16950946 (pathophysiology) "Ictal epileptic discharges in Panayiotopoulos syndrome, irrespective of their location at onset, activate autonomic disturbances and emesis, to which children are particularly vulnerable."
16483404 Ferrie 2006 consensus "We conclude that PS is a common idiopathic, benign seizure disorder of childhood, which should be classified as an autonomic epilepsy, rather than an occipital epilepsy."
35503717 ILAE 2022 nosology "self-limited focal epilepsies, comprising four syndromes: self-limited epilepsy with centrotemporal spikes, self-limited epilepsy with autonomic seizures, childhood occipital visual epilepsy, and photosensitive occipital lobe epilepsy"
20528983 Specchio 2010, n=93 "Of 1,794 children aged between 1 and 14 years referred for the first afebrile focal seizure, between January 1992 and December 2004, 93 (5.2%) had PS according to clinical criteria."
20528983 (seizure duration is not prognostic) "More than half (55%) of seizures were longer than 30 min but these did not appear to affect remission and number of seizures."
17442007 Caraballo 2007, n=192 "Eighty-four (44.2%) had a single seizure, 79 (41.2%) had 2-5 fits, and 28 (14.6%) had frequent seizures."
29571057 Weir 2018, incidence "The incidence of PS and BECTS was found to be 0.8 and 6.1 per 100,000 <16 year olds, respectively."
17441996 Koutroumanidis 2007, "system epilepsy" "These typical electroclinical features do not allow straightforward assignment to a distinctive cortical area, rendering the term 'focal'--as we currently understand it--problematic."
37660659 Oguni 2023, EEG reappraisal "The interictal EEG characteristics of SeLEAS are multifocal EEG foci with age-dependent predominant locations; occipital (O) at 2-5 years old, and occipital and frontopolar (synchronous and independent O and Fp spikes) at 4-7 years old and centro-parieto-temporal (CPT) at 6-10 years old."
28192756 Kivity 2017, SCN1A "A pathogenic heterozygous SCN1A (c.2624C>A; p.Thr875Lys) variant was identified. Sixteen of the 18 variant positive family members were affected (88% penetrance)"
18669497 Taylor 2008, twins "Monozygotic twin pairs did not show a higher concordance rate than dizygotic twin pairs suggesting that BOEC may not be a purely genetic disorder."
32600977 Rudolf 2020, exome "Our results further illustrate the fact that atypical SFEC are more likely to have Mendelian inheritance than typical SFEC."
35153087 Kawakami 2022, vs encephalopathy "seizures were treatable in all patients with PS with a small dose of midazolam (0.1 mg/kg), but all patients with acute encephalopathy required midazolam at 0.3 mg/kg or more (P < 0.001)"
17442005 Ferrie 2007, autonomic SE definition "Autonomic SE is a condition lasting at least 30 min and characterized by epileptic activity causing altered autonomic function of any type at seizure onset"
32608507 Fonseca Wald 2020, cognition "Children with Panayiotopoulos syndrome demonstrated diffuse cognitive dysfunction in full-scale IQ, performance IQ, visual attention, visual-motor integration, and verbal memory."
25202134 Mellish 2015, UK practice "Clinicians reported non-treatment in 40%: main reasons were low frequency of seizures and parent/child preferences. Carbamazepine is the preferred older, and levetiracetam the preferred newer, RCT arm."
37918221 Fujita 2023, HFO biomarker "seizures did not occur if HFOs disappeared even if the spikes remained"
42348808 Berg 2026, migraine mimicry "In total, 18.8% (n = 35) of pediatric patients initially diagnosed with 'migraine' or 'headache' received a possible, probable, or definite diagnosis of benign focal epilepsy with autonomic seizures."
21822089 Mujawar 2011, cardiorespiratory arrest "ictal cardiorespiratory arrest is extremely rare, with only 4 cases being reported in literature."
35871494 Cooper 2023, cerebral palsy variant "Self-limited focal epilepsy-variant usually manifested with a mix of autonomic and brachio-facial motor features, and occipital and/or centro-temporal spikes on EEG."
35063695 Semprino 2022, unusual presentations "Twelve patients (29.2%) had ictal syncope or syncope-like epileptic seizures."
24840752 Değerliyurt 2014, Turkish series "Evolution to electrical status epilepticus in sleep and Gastaut-type epilepsy were seen in patients with more than ten seizures."
31369969 Graziosi 2019, misdiagnosis "The consequences are high morbidity, costly mismanagement, and stress for children and their parents."
35740751 Zontek & Paprocka 2022, CAN review "The purpose of this review is to underline the role of central autonomic network dysfunction in the development of Panayiotopoulos syndrome"
31398558 Akca Kalem 2019, PS vs Gastaut "Cognitive dysfunction is a more prominent and widespread feature of the patients with PS; whereas, the patients with GS suffer only from milder and isolated cognitive problems."
24777033 Tata 2014, PS vs symptomatic OLE "Panayiotopoulos syndrome differs from symptomatic occipital lobe epilepsy and has a unique low epileptogenic threshold related to particular brain circuits."
37714124 Quito-Betancourt 2023, nomenclature "Using the term 'benign' to refer to them is no longer recommended, as this would ignore the comorbidities some individuals suffer."

Sources